| 1190002N15Rik-CKO |
NM-CKO-00008 |
1190002N15Rik |
|
| 1300017j02Rik-KO |
NM-KO-190231 |
1300017j02Rik |
Immune-related |
| 1700074P13Rik-KO |
NM-KO-00025 |
1700074P13Rik |
|
| 1700121C10Rik-KO |
NM-KO-190450 |
1700121C10Rik |
unknown |
| 2310057M21Rik-KO |
NM-KO-190232 |
2310057M21Rik |
Immune-related |
| 4930578C19Rik-CKO |
NM-CKO-00003 |
4930578C19Rik |
|
| Abcb11-KO |
NM-KO-18010 |
Abcb11 |
|
| Abcc1-KO |
NM-KO-18012 |
Abcc1 |
|
| Abcc2-KO |
NM-KO-18017 |
Abcc2 |
|
| Abcg2-KO |
NM-KO-18013 |
Abcg2 |
|
| Abi3bp-CKO |
NM-CKO-00009 |
Abi3bp |
Cancer and stem cells research |
| Abtb1-KO |
NM-KO-00001 |
Abtb1 |
liver injury and regeneration |
| Acadsb-KO |
NM-KO-190233 |
Acadsb |
Immune-related |
| H11-(ACHE) |
NM-KI-00067 |
ACHE |
Cholinesterase related drug research |
| Acot7-CKO |
NM-CKO-00045 |
Acot7 |
Biosynthesis of unsaturated fatty acids,Fatty acid elongation,fatty acid metabolism |
| Adgra1-CKO |
NM-CKO-00100 |
Adgra1 |
cardiovascular system，nervous system |
| Adgra2-CKO |
NM-CKO-00101 |
Adgra2 |
|
| Adgrd1-KO |
NM-KO-190234 |
Adgrd1 |
Immune-related |
| Adgrd1-CKO |
NM-CKO-00097 |
Adgrd1 |
|
| Adgre1-(2A-CreERT2) |
NM-KI-190025 |
Adgre1 |
Cre recombinase tool |
| Adgrf1-KO |
NM-KO-00059 |
Adgrf1 |
|
| Adgrf4-KO |
NM-KO-00055 |
Adgrf4 |
|
| Adgrf5-CKO |
NM-CKO-00095 |
Adgrf5 |
cardiovascular system，homeostasis/metabolism，aging |
| Adgrg3-KO |
NM-KO-00054 |
Adgrg3 |
|
| Adgrg6-CKO |
NM-CKO-00096 |
Adgrg6 |
|
| Adgrg7-KO |
NM-KO-00056 |
Adgrg7 |
Digestive system related. |
| Adipoq-KO |
NM-KO-190438 |
Adipoq |
lipid metabolism |
| Adipoq-KO |
NM-KO-00003 |
Adipoq |
lipid metabolism |
| Ado-KO |
NM-KO-190236 |
Ado |
Immune-related |
| Afp-CreERT2 |
NM-TG-00009 |
Afp-CreERT2 |
Cre recombinase tool of liver |
| Agk-CKO |
NM-CKO-00026 |
Agk |
|
| Agr3-KO |
NM-KO-190237 |
Agr3 |
Immune-related |
| Agrt1a-KO |
NM-KO-00041 |
Agrt1a |
cardiovascular system,nervous system |
| Ahcy-KO |
NM-KO-190238 |
Ahcy |
Immune-related |
| Ahi1-CKO |
NM-CKO-00053 |
Ahi1 |
|
| Ahnak-KO |
NM-KO-190239 |
Ahnak |
Immune-related |
| Ahr-KO |
NM-KO-18008 |
Ahr |
|
| Aimp1-CKO |
NM-CKO-00064 |
Aimp1 |
immune system，hematopoietic system |
| Alb-(CreERT2) |
NM-KI-00002 |
Alb |
cre-mediated recombination system |
| Alkbh3-KO |
NM-KO-190240 |
Alkbh3 |
Immune-related |
| Alkbh5-KO |
NM-KO-190448 |
Alkbh5 |
mRNA methylation |
| R26-(CAG-LSL-ALKBH5-3xFLAG-IRES-EGFP) |
NM-KI-190054 |
Alkbh5 |
mRNA methylation |
| Alkbh5-CKO |
NM-CKO-190004 |
Alkbh5 |
Epigenetic |
| Alpl-KO |
NM-KO-18058 |
Alpl |
|
| Amhr2-(Cre) |
NM-KI-190012 |
Amhr2 |
Tool Mice |
| Angptl8-KO |
NM-KO-190241 |
Angptl8 |
Immune-related |
| Anp32b-CKO |
NM-CKO-00043 |
Anp32b |
|
| Aoah-KO |
NM-KO-190242 |
Aoah |
Immune-related |
| Apcs-KO |
NM-KO-190001 |
Apcs |
Immune-related |
| Aplnr-DreERT2 |
NM-KI-00132 |
Aplnr |
recombinase tool |
| Apob-(Q1388H) |
NM-KI-00056 |
Apob |
lipid metabolism studies, cardiovascular disease research |
| APOE2-HU |
NM-HU-190013 |
Apoe |
Immune-related |
| APOE4-HU |
NM-HU-190002 |
Apoe |
Cardiovascular disease |
| APOE3-HU |
NM-HU-190003 |
Apoe |
Cardiovascular disease |
| Apoe-KO |
NM-KO-00033 |
Apoe |
Atherosclerosis,hyperlipidemia,hypercholesterolemia,cerebral infarction,AD,chronic hepatitis etc. |
| App-KO |
NM-KO-190444 |
App |
neuronal differentiation/migration, synaptic regulation and Alzheimer's disease related |
| Appl1-CKO |
NM-CKO-00118 |
Appl1 |
|
| Appl2-CKO |
NM-CKO-00112 |
Appl2 |
|
| Aqp4-KO |
NM-KO-190243 |
Aqp4 |
Immune-related |
| Aqp5-KO |
NM-KO-190244 |
Aqp5 |
Immune-related |
| Ar-CKO |
NM-CKO-00110 |
Ar |
|
| Areg-KO |
NM-KO-190002 |
Areg |
Immune-related |
| Arih1-KO |
NM-KO-190245 |
arih1 |
Immune-related |
| Asap3-CKO |
NM-CKO-00038 |
Asap3 |
|
| Asgr1-KO |
NM-KO-190246 |
Asgr1 |
Immune-related |
| Atg5-KO |
NM-KO-18004 |
Atg5 |
|
| Atg5-CKO |
NM-CKO-00131 |
Atg5 |
Autophagy, Atg5 function study |
| Atp5b-KO |
NM-KO-190247 |
Atp5b |
Immune-related |
| Atp7b-(H1071Q) |
NM-KI-18001 |
Atp7b |
|
| Atpaf1-KO |
NM-KO-190248 |
Atpaf1 |
Immune-related |
| Atpaf2-KO |
NM-KO-190249 |
Atpaf2 |
Immune-related |
| AU021092-CKO |
NM-CKO-00111 |
AU021092 |
|
| B2m-KO(M-NSG) |
NM-NSG-002 |
B2m |
immunodeficiency,immune system,transplantation research |
| B2m-KO(NOD-scid) |
NM-KO-18035 |
B2m |
immunodeficiency,immune system,transplantation research |
| B2m-KO |
NM-KO-18021 |
B2m |
immune system |
| Batf3-KO |
NM-KO-190447 |
Batf3 |
Immune-related, CD8 deficiency |
| BC028528-CKO |
NM-CKO-00012 |
BC028528 |
|
| Becn1-KO |
NM-KO-18028 |
Becn1 |
autophagy, cancer research |
| Becn1-CKO |
NM-CKO-18008 |
Becn1 |
cancer research,Autophagy |
| R26-(BirA) |
NM-KI-00085 |
BirA |
|
| Bmf-KO |
NM-KO-190003 |
Bmf |
Immune-related |
| Bnipl-CKO |
NM-CKO-00062 |
Bnipl |
|
| Boll-KO |
NM-KO-190004 |
Boll |
Immune-related |
| Bpifa1-CKO |
NM-CKO-00074 |
Bpifa1 |
Epigenetic regulation of gene expression，nervous system |
| Braf-(flox-V600E) |
NM-KI-190053 |
Braf |
cancer research |
| Brca1-CKO |
NM-CKO-18007 |
Brca1 |
cancer research |
| Brd7-CKO |
NM-CKO-00034 |
Brd7 |
|
| Btbd10-KO |
NM-KO-00043 |
Btbd10 |
|
| Btk-KO |
NM-KO-190005 |
Btk |
Immune-related |
| BTLA-HU |
NM-HU-190040 |
Btla |
Immunotherapy,cancer research,drug screening |
| Btla-KO |
NM-KO-18051 |
Btla |
|
| Btnl9-KO |
NM-KO-190250 |
Btnl9 |
Immune-related |
| C1qtnf1-KO |
NM-KO-190251 |
C1qtnf1 |
Immune-related |
| C2-KO |
NM-KO-190179 |
C2 |
Immune-related |
| C5ar1-KO |
NM-KO-190180 |
C5ar1 |
Immune-related |
| CAG-GFP |
NM-TG-00005 |
CAG-GFP |
Reporter mice,EGFP |
| Cand1-KO |
NM-KO-190252 |
Cand1 |
Immune-related |
| Car2-KO |
NM-KO-190006 |
Car2 |
Immune-related |
| Carm1-CKO |
NM-CKO-190015 |
Carm1 |
Epigenetic |
| Cars-KO |
NM-KO-190253 |
Cars |
Immune-related |
| R26-(CAG-LSL-Cas13d-IRES-tdTomato) |
NM-KI-190063 |
Cas13d |
RNA editing,Cas13d |
| R26-(Cas9) |
NM-KI-00120 |
Cas9 |
gene editing, gene modification |
| R26-(CAG-LNL-Cas9-IRES-Luciferase-pA)1 |
NM-KI-18002 |
Cas9 |
Cas9,gene editing |
| R26-(Cas9) |
NM-KI-00038 |
Cas9 |
gene editing, gene modification |
| Casp1-KO |
NM-KO-190443 |
Casp1 |
Inflammation and cell death |
| Casp4-CKO |
NM-CKO-190061 |
Casp4 |
cell pyroptosis, cell apoptosis |
| Casp8-KO |
NM-KO-190440 |
Casp8 |
cancer research,Apoptosis |
| Casp8-CKO |
NM-CKO-190003 |
Casp8 |
cancer research,Apoptosis |
| Cbl-KO |
NM-KO-190007 |
Cbl |
Immune-related |
| Cblb-KO |
NM-KO-190008 |
Cblb |
Immune-related |
| Cblif-KO |
NM-KO-190089 |
Cblif |
Immune-related |
| Cbx7-CKO |
NM-CKO-00114 |
Cbx7 |
|
| Ccdc3-CKO |
NM-CKO-00082 |
Ccdc3 |
mortality/aging，nervous system |
| Ccl1-KO |
NM-KO-190009 |
Ccl1 |
Immune-related |
| Ccl17-KO |
NM-KO-190010 |
Ccl17 |
Immune-related |
| Ccl19-KO |
NM-KO-190011 |
Ccl19 |
Immune-related |
| Ccl20-KO |
NM-KO-190012 |
Ccl20 |
Immune-related |
| Ccl22-KO |
NM-KO-190013 |
Ccl22 |
Immune-related |
| Ccl25-KO |
NM-KO-190015 |
Ccl25 |
Immune-related |
| Ccl28-KO |
NM-KO-00166 |
Ccl28 |
|
| Ccl3-KO |
NM-KO-190014 |
Ccl3 |
Immune-related |
| Ccl4-KO |
NM-KO-190016 |
Ccl4 |
Immune-related |
| Ccl5-KO |
NM-KO-190017 |
Ccl5 |
Immune-related |
| Ccny-CKO |
NM-CKO-00071 |
Ccny |
|
| Ccr10-KO |
NM-KO-190019 |
Ccr10 |
Immune-related |
| Ccr2-KO |
NM-KO-190018 |
Ccr2 |
Immune-related |
| CCR2-HU |
NM-HU-18026 |
Ccr2 |
Immunotherapy,Cancer research,Drug screening |
| Ccr3-KO |
NM-KO-190020 |
Ccr3 |
Immune-related |
| CCR4-HU |
NM-HU-190054 |
Ccr4 |
Immunotherapy,cancer research,drug screening |
| Ccr5-KO |
NM-KO-190021 |
Ccr5 |
Immune-related |
| Ccr6-KO |
NM-KO-190022 |
Ccr6 |
Immune-related |
| Ccr7-KO |
NM-KO-190023 |
Ccr7 |
Immune-related |
| CCR8-HU |
NM-HU-190053 |
Ccr8 |
Immunotherapy,cancer research,drug screening |
| Ccr8-KO |
NM-KO-190024 |
Ccr8 |
Immune-related |
| Ccr9-KO |
NM-KO-190025 |
Ccr9 |
Immune-related |
| Cct4-KO |
NM-KO-190254 |
Cct4 |
Immune-related |
| Cd14-KO |
NM-KO-190026 |
Cd14 |
Immune-related |
| Cd163-KO |
NM-KO-190027 |
Cd163 |
Immune-related |
| Cd19-(IRES-DTREGFP） |
NM-KI-190042 |
Cd19 |
DTR mouse |
| CD19&CD3E-HU |
NM-HU-190027 |
Cd19，Cd3e |
Immune-related |
| CD19-KO |
NM-KO-18001 |
Cd19 |
|
| CD19-HU |
NM-HU-00110 |
Cd19 |
Immunotherapy,cancer research,drug screening |
| Cd2-KO |
NM-KO-190028 |
Cd2 |
Immune-related |
| Cd2-(2A-CreERT2-WPRE-pA) |
NM-KI-18017 |
Cd2 |
Cre recombinase tool |
| Cd200-KO |
NM-KO-190029 |
Cd200 |
Immune-related |
| Cd207-KO |
NM-KO-190030 |
Cd207 |
Immune-related |
| Cd209a-KO |
NM-KO-190255 |
Cd209a |
Immune-related |
| Cd244a-KO |
NM-KO-190032 |
Cd244a |
Immune-related |
| Cd24a-KO |
NM-KO-190031 |
Cd24a |
Immune-related |
| CD27-HU |
NM-HU-190035 |
Cd27 |
Immunotherapy,cancer research,drug screening |
| Cd27-KO |
NM-KO-190033 |
Cd27 |
Immune-related |
| PD-L1-HU |
NM-HU-190039 |
Cd274 |
Immunotherapy,cancer research,drug screening |
| PD-L1&SEMA4D-HU |
NM-HU-190034 |
Cd274，Sema4d |
Immunotherapy,cancer research,drug screening |
| PD-L1&GITR-HU |
NM-HU-190015 |
Cd274，Tnfrsf18 |
Immune-related |
| PD-L1&CD40-HU |
NM-HU-18024 |
Cd274，Cd40 |
Immunotherapy,cancer research,drug screening |
| Cd274-KO |
NM-KO-18044 |
Cd274 |
inflammatory,immune system |
| PD-L1&LAG3-HU |
NM-HU-00137 |
Cd274，Lag3 |
Immunotherapy,cancer research,drug screening |
| PD-L1&4-1BB-HU |
NM-HU-00138 |
Cd274，Tnfrsf9 |
Immunotherapy,cancer research,drug screening |
| PD-L1&TIGIT-HU |
NM-HU-18013 |
Cd274，Tigit |
Immunotherapy,cancer research,drug screening |
| PD-L1&OX40-HU |
NM-HU-00111 |
Cd274，Tnfrsf4 |
cancer research,Immunotherapy,drug screening |
| PD-L1-HU |
NM-HU-00062 |
Cd274 |
Immunotherapy,cancer research,drug screening |
| Cd276-KO |
NM-KO-18039 |
Cd276 |
inflammation, autoimmunity |
| CD28-HU |
NM-HU-190011 |
Cd28 |
Immune-related |
| Cd28-KO |
NM-KO-190034 |
Cd28 |
Immune-related |
| Cd34-KO |
NM-KO-190035 |
Cd34 |
Immune-related |
| CD36-HU |
NM-HU-00112 |
Cd36 |
Immunotherapy,cancer research,drug screening |
| Cd38-KO |
NM-KO-190036 |
Cd38 |
Immune-related |
| CD3E-HU |
NM-HU-00114 |
Cd3e |
Immunotherapy,cancer research,drug screening |
| Cd4-KO |
NM-KO-190441 |
Cd4 |
immune system, immunodeficiency |
| Cd4-(2A-DreERT2） |
NM-KI-190030 |
Cd4 |
Dre recombinase tool |
| Cd4-KO |
NM-KO-18023 |
Cd4 |
immune system, immunodeficiency |
| CD4-HU |
NM-HU-00115 |
Cd4 |
Immunotherapy,cancer research,drug screening |
| Cd40-KO |
NM-KO-190038 |
Cd40 |
Immune-related |
| CD40-HU |
NM-HU-00076 |
Cd40 |
cancer research,Immunotherapy,drug screening |
| Cd44-KO |
NM-KO-190039 |
Cd44 |
Immune-related |
| R26-(SA-CD46-IRES-tdTomato) |
NM-KI-190087 |
CD46 |
Immune-related |
| Cd46-KO |
NM-KO-190040 |
Cd46 |
Immune-related |
| Cd47-KO |
NM-KO-190041 |
Cd47 |
Immune-related |
| CD47-HU |
NM-HU-00050 |
Cd47 |
Immunotherapy,cancer research,drug screening |
| Cd5-KO |
NM-KO-190042 |
Cd5 |
Immune-related |
| Cd6-KO |
NM-KO-190043 |
Cd6 |
Immune-related |
| Cd63-KO |
NM-KO-190044 |
Cd63 |
Immune-related |
| Cd68-(CreERT2) |
NM-KI-190013 |
Cd68 |
Tool Mice |
| Cd68-KO |
NM-KO-190045 |
Cd68 |
Immune-related |
| Cd69-KO |
NM-KO-190046 |
Cd69 |
Immune-related |
| Cd7-KO |
NM-KO-190047 |
Cd7 |
Immune-related |
| Cd70-KO |
NM-KO-190048 |
Cd70 |
Immune-related |
| Cd79a-KO |
NM-KO-190049 |
Cd79a |
Immune-related |
| Cd80-KO |
NM-KO-190184 |
Cd80 |
Immune-related |
| CD80-HU |
NM-HU-00074 |
Cd80 |
cancer research,immune system |
| CD81-HU |
NM-HU-190041 |
Cd81 |
Immunotherapy,cancer research,drug screening |
| Cd83-KO |
NM-KO-190051 |
Cd83 |
Immune-related |
| Cd86-KO |
NM-KO-18041 |
Cd86 |
immune system |
| CD86-HU |
NM-HU-00045 |
Cd86 |
Immunotherapy,cancer research,drug screening |
| Cd8a-(IRES-DTREGFP） |
NM-KI-190045 |
Cd8a |
DTR mouse |
| Cd8a-KO |
NM-KO-190181 |
Cd8a |
Immune-related |
| Cd8a-(V5-IRES-luci-2A-EGFP) |
NM-KI-18030 |
Cd8a |
gene tracing |
| Cd8b1-KO |
NM-KO-190183 |
Cd8b1 |
Immune-related |
| Cdh1-(2A-DreERT2） |
NM-KI-190031 |
Cdh1 |
Dre recombinase tool |
| Cdh1-CKO |
NM-CKO-18016 |
Cdh1 |
|
| Cdk12-CKO |
NM-CKO-190059 |
Cdk12 |
Cancer |
| Cdk2-KO |
NM-KO-190052 |
Cdk2 |
Immune-related |
| Cdk5r1-KO |
NM-KO-190256 |
Cdk5r1 |
Immune-related |
| Cdk5rap2-CKO |
NM-CKO-00055 |
Cdk5rap2 |
Hertwig's anemia. |
| Cdk9-KO |
NM-KO-190053 |
Cdk9 |
Immune-related |
| Cdkn2a-(Luc-tdTomato-CreERT2) |
NM-KI-18039 |
Cdkn2a |
|
| Ceacam1-KO |
NM-KO-190054 |
Ceacam1 |
Immune-related |
| CEACAM1-HU |
NM-HU-00116 |
Ceacam1 |
Immunotherapy,cancer research,drug screening |
| Cela1-(2A-DreERT2) |
NM-KI-190094 |
Cela1 |
Dre recombinase tool, pancreatic acinar cells |
| Cenpx-CKO |
NM-CKO-190056 |
Cenpx |
Epigenetic |
| Cers2-CKO |
NM-CKO-00052 |
Cers2 |
|
| Cgn-KO |
NM-KO-190055 |
Cgn |
Immune-related |
| Chd3-CKO |
NM-CKO-00037 |
Chd3 |
|
| Chid1-KO |
NM-KO-00029 |
Chid1 |
immune system,metabolism |
| Chrna7-Fan1-KO |
NM-KO-18062 |
Chrna7，Fan1 |
|
| Ciita-KO |
NM-KO-190056 |
Ciita |
Immune-related |
| Cirbp-KO |
NM-KO-190257 |
Cirbp |
Immune-related |
| Clec10a-KO |
NM-KO-190221 |
Clec10a |
Immune-related |
| Clec12a-KO |
NM-KO-190222 |
Clec12a |
Immune-related |
| Clec12b-KO |
NM-KO-190223 |
Clec12b |
Immune-related |
| Clec18a-CKO |
NM-CKO-00006 |
Clec18a |
|
| Clec1b-KO |
NM-KO-190229 |
Clec1b |
Immune-related |
| Clec3b-KO |
NM-KO-00169 |
Clec3b |
|
| Clec4a2-KO |
NM-KO-190214 |
Clec4a2 |
Immune-related |
| Clec4e-KO |
NM-KO-190215 |
Clec4e |
Immune-related |
| Clec4n-KO |
NM-KO-190217 |
Clec4n |
Immune-related |
| Clec5a-KO |
NM-KO-190205 |
Clec5a |
Immune-related |
| Clec7a-KO |
NM-KO-190219 |
Clec7a |
Immune-related |
| Clec9a-KO |
NM-KO-190204 |
Clec9a |
Immune-related |
| Clta-KO |
NM-KO-190057 |
Clta |
Immune-related |
| CMV-GFP |
NM-TG-00006 |
CMV-GFP |
Reporter mice,EGFP |
| Col10a1-KO |
NM-KO-190258 |
Col10a1 |
Immune-related |
| Col2a1-(2A-CreERT2) |
NM-KI-18029 |
Col2a1 |
Cre recombinase tool |
| Cop1-KO |
NM-KO-190058 |
Cop1 |
Immune-related |
| Cort-KO |
NM-KO-190059 |
Cort |
Immune-related |
| Cpm-KO |
NM-KO-190060 |
Cpm |
Immune-related |
| Cpt1a-CKO |
NM-CKO-00056 |
Cpt1a |
Circadian Clock,Fatty acid metabolism,Carnitine Palmitoyltransferase IA Deficiency |
| Cptp-KO |
NM-KO-190061 |
Cptp |
Immune-related |
| Cr2-KO |
NM-KO-190185 |
Cr2 |
Immune-related |
| Crebbp-CKO |
NM-CKO-190016 |
Crebbp |
Epigenetic |
| Crem-KO |
NM-KO-190062 |
Crem |
Immune-related |
| CSF1-HU |
NM-HU-190043 |
Csf1 |
Immunotherapy,cancer research,drug screening |
| Csf1-KO |
NM-KO-190063 |
Csf1 |
Immune-related |
| Csf1r-(IRES-iCre） |
NM-KI-190026 |
Csf1r |
Cre recombinase tool |
| CSF2-HU |
NM-HU-190046 |
Csf2 |
Immunotherapy,cancer research,drug screening |
| CSF3-HU |
NM-HU-190006 |
Csf3 |
Immune-related |
| Cspg4-(2A-DreERT2） |
NM-KI-190038 |
Cspg4 |
Dre recombinase tool |
| Ctcfl-KO |
NM-KO-190259 |
Ctcfl |
Immune-related |
| Cth-(Luc) |
NM-KI-00004 |
Cth |
homeostasis,liver，renal function related research and Cystathioninuria study |
| CTLA4-HU |
NM-HU-190038 |
Ctla4 |
Immunotherapy,cancer research,drug screening |
| CTLA4&4-1BB-HU |
NM-HU-18020 |
Ctla4，Tnfrsf9 |
Immunotherapy,cancer research,drug screening |
| CTLA4-HU |
NM-HU-00014 |
Ctla4 |
cancer research,Immunotherapy,drug screening； |
| PD-L1&CTLA4-HU |
NM-HU-00102 |
Ctla4，Cd274 |
Immunotherapy,cancer research,drug screening |
| Ctsk-(2A-Cre) |
NM-KI-190019 |
Ctsk |
Cre recombinase tool |
| Cx3cl1-KO |
NM-KO-190064 |
Cx3cl1 |
Immune-related |
| Cx3cr1-KO |
NM-KO-190065 |
Cx3cr1 |
Immune-related |
| Cxcl10-KO |
NM-KO-190066 |
Cxcl10 |
Immune-related |
| Cxcl13-KO |
NM-KO-190067 |
Cxcl13 |
Immune-related |
| Cxcl9-KO |
NM-KO-190069 |
Cxcl9 |
Immune-related |
| Cxcr1-KO |
NM-KO-190068 |
Cxcr1 |
Immune-related |
| Cxcr2-KO |
NM-KO-190070 |
Cxcr2 |
Immune-related |
| CXCR2-HU |
NM-HU-18025 |
Cxcr2 |
Immunotherapy,Cancer research,Drug screening |
| Cxcr3-KO |
NM-KO-190071 |
Cxcr3 |
Immune-related |
| Cxcr4-KO |
NM-KO-190072 |
Cxcr4 |
Immune-related |
| Cxcr5-KO |
NM-KO-190073 |
Cxcr5 |
Immune-related |
| Cybb-KO |
NM-KO-18031 |
Cybb |
CGD, inflammatory |
| Cyp1a1-Cyp1a2-KO |
NM-KO-18018 |
Cyp1a1，Cyp1a2 |
|
| Cyp2c cluster-KO |
NM-KO-18019 |
Cyp2c cluster |
drug development |
| R26-(Liver-CYP3A4) |
NM-KI-18032 |
CYP3A4 |
metabolism |
| R26-(Gut-CYP3A4) |
NM-KI-18033 |
CYP3A4 |
metabolism |
| Cyp3a-KO |
NM-KO-190427 |
Cyp3a57 |
|
| Cyp3a-KO |
NM-KO-18056 |
Cyp3a57 |
|
| R26-(CAG-LSL-Avi-dCas9-IRES-EGFP) |
NM-KI-18031 |
dCas9 |
|
| R26-(CAG-LSL-dCas9-VPR-IRES-EGFP-WPRE-pA) |
NM-KI-18004 |
dCas9 |
gene regulation tool,CRISPRa |
| R26-e(CAG-LSL-KRAB-dCas9-IRES-EGFP) |
NM-KI-18007 |
dCas9 |
CRISPRi,gene regulation tool |
| CAG-LSL-dCas9-SPH |
NM-TG-00025 |
dCas9 |
gene regulation tool,CRISPRa |
| Col1a1-(TRE3G-dCas9-VPR-eGFP-pA) |
NM-KI-00123 |
dCas9 |
gene regulation tool,CRISPRa |
| Dct-KO |
NM-KO-190074 |
Dct |
Immune-related |
| R26-(ddCas9) |
NM-KI-00063 |
ddCas9 |
gene editing, gene modification |
| H11-(ddCre) |
NM-KI-00086 |
ddCre |
|
| Ddx58-KO |
NM-KO-18063 |
Ddx58 |
|
| Dennd3-KO |
NM-KO-190260 |
Dennd3 |
Immune-related |
| Des-KO |
NM-KO-190261 |
Des |
Immune-related |
| Dexi-KO |
NM-KO-190262 |
Dexi |
Immune-related |
| Dgcr2-Hira-KO |
NM-KO-18060 |
Dgcr2，Hira |
behavior, cardiovascular, mortality/aging, nervous system |
| Dhodh-KO |
NM-KO-190263 |
Dhodh |
Immune-related |
| Dhtkd1-(Y485X) |
NM-KI-00005 |
Dhtkd1 |
|
| Dmd-（c.C2983T） |
NM-KI-18026 |
Dmd |
|
| Dnmt1-CKO |
NM-CKO-190046 |
Dnmt1 |
Epigenetic |
| Dnmt3a-CKO |
NM-CKO-190047 |
Dnmt3a |
Epigenetic |
| Dnmt3b-CKO |
NM-CKO-190017 |
Dnmt3b |
Epigenetic |
| Dnmt3l-CKO |
NM-CKO-190018 |
Dnmt3l |
Epigenetic |
| Dock6-KO |
NM-KO-190264 |
Dock6 |
Immune-related |
| DPP4-HU |
NM-HU-190042 |
Dpp4 |
Immunotherapy,cancer research,drug screening |
| Dpp8-CKO |
NM-CKO-00047 |
Dpp8 |
|
| Dppa3-(Cre) |
NM-KI-00040 |
Dppa3 |
Cre recombinase tool |
| Dr1-KO |
NM-KO-190075 |
Dr1 |
Immune-related |
| Drd1-(2A-CreERT2-WPRE-pA) |
NM-KI-18016 |
Drd1 |
Cre recombinase tool |
| Drd2-KO |
NM-KO-190265 |
Drd2 |
Immune-related |
| CAG-Dre |
NM-TG-00026 |
Dre |
Dre recombinase tool |
| R26-(CAG-LSL-RSR-tdTomato-2A-DTR) |
NM-KI-190086 |
DTR |
Dre and Dre reporter |
| Dtx1-KO |
NM-KO-190077 |
Dtx1 |
Immune-related |
| R26-(Dusp12) |
NM-KI-18038 |
Dusp12 |
|
| Dusp12-KO |
NM-KO-18054 |
Dusp12 |
|
| Dyrk4-KO |
NM-KO-190266 |
Dyrk4 |
Immune-related |
| E330021D16Rik-KO |
NM-KO-190267 |
E330021D16Rik |
Immune-related |
| Ebf1-CKO |
NM-CKO-00065 |
Ebf1 |
not clear |
| Ebi3-KO |
NM-KO-190076 |
Ebi3 |
Immune-related |
| Eed-CKO |
NM-CKO-190019 |
Eed |
Epigenetic |
| H11-(EGFP) |
NM-KI-00066 |
EGFP |
gene tracing,Reporter mice, EGFP |
| R26-(CAG-LSL-EGFR-IRES-luciferase-2A-tdTomato) |
NM-KI-190066 |
EGFR |
cancer research |
| R26-(CAG-LSL-EGFR (L858R-T790M-C797S)-IRES-luciferase-2A-tdTomato) |
NM-KI-190067 |
EGFR |
cancer research |
| R26-(CAG-LSL-EGFR (L858R-T790M)-IRES-luciferase-2A-tdTomato) |
NM-KI-190068 |
EGFR |
cancer research |
| R26-(CAG-LSL-EGFR(L858R)-IRES-Luciferase-2A-tdTomato) |
NM-KI-190069 |
EGFR |
cancer research |
| R26-(CAG-LSL-EGFR(T790M) -IRES-Luciferase-2A-tdTomato) |
NM-KI-190070 |
EGFR |
cancer research |
| Egfr-KO |
NM-KO-190268 |
Egfr |
Immune-related |
| Egfr-CKO |
NM-CKO-00133 |
Egfr |
cancer research, EGFR fuction study |
| Ehd4-KO |
NM-KO-190269 |
Ehd4 |
Immune-related |
| Ehmt1-CKO |
NM-CKO-190020 |
Ehmt1 |
Epigenetic |
| Ehmt2-CKO |
NM-CKO-190048 |
Ehmt2 |
Epigenetic |
| Elf1-KO |
NM-KO-190270 |
Elf1 |
Immune-related |
| Emc10-CKO |
NM-CKO-00084 |
Emc10 |
cancer，nervous system |
| R26-(CAG-LSL-EML4-ALK-IRES-Luciferase-2A-tdTomato) |
NM-KI-190072 |
EML4-ALK |
cancer research |
| Enpp6-KO |
NM-KO-00020 |
Enpp6 |
Ether lipid metabolism |
| Entpd1-KO |
NM-KO-190078 |
Entpd1 |
Immune-related |
| Ep300-CKO |
NM-CKO-190021 |
Ep300 |
Epigenetic |
| Epcam-(CreERT2) |
NM-KI-00084 |
Epcam |
|
| Ephb2-KO |
NM-KO-190271 |
Ephb2 |
Immune-related |
| R26-(CAG-LSL-ERBB2(exon20 insertion)-IRES-Luciferase-2A-EGFP) |
NM-KI-190071 |
ERBB2 |
cancer research |
| Ern1-CKO |
NM-CKO-00077 |
Ern1 |
|
| Esrra-CKO |
NM-CKO-00039 |
Esrra |
Metabolism，Metabolism of lipids and lipoproteins，Mitochondrial biogenesis |
| Exoc6b-CKO |
NM-CKO-00138 |
Exoc6b |
|
| R26-(CAG-LSL-EZH2(Y646N)-IRES-Luciferase-2A-tdTomato) |
NM-KI-190073 |
EZH2 |
cancer research |
| Ezh2-CKO |
NM-CKO-190022 |
Ezh2 |
Epigenetic |
| F8-KO |
NM-KO-00012 |
F8 |
Hemophilia A;HEMA |
| F9-KO |
NM-KO-18046 |
F9 |
factor IX (F9) function and gene therapy |
| Faap100-KO |
NM-KO-190272 |
Faap100 |
Immune-related |
| Fam19a2-KO |
NM-KO-00045 |
Fam19a2 |
|
| Fam220a-KO |
NM-KO-190273 |
Fam220a |
Immune-related |
| Fap-KO |
NM-KO-190079 |
Fap |
Immune-related |
| Fas-KO |
NM-KO-190080 |
Fas |
Immune-related |
| Fau-CKO |
NM-CKO-00048 |
Fau |
|
| Fbln5-KO |
NM-KO-190274 |
Fbln5 |
Immune-related |
| Fbln7-CKO |
NM-CKO-00120 |
Fbln7 |
|
| Fcer1g-KO |
NM-KO-190187 |
Fcer1g |
Immune-related |
| Fcgr1-KO |
NM-KO-18033 |
Fcgr1 |
immunodeficiency, immune system |
| Fcgr2b/Fcgr3/Fcgr4-KO |
NM-KO-18037 |
Fcgr2b，Fcgr3，Fcgr4 |
inflammation,autoimmunity |
| Fcgr2b-KO |
NM-KO-00130 |
Fcgr2b |
immune system |
| Fcgr3-KO |
NM-KO-190189 |
Fcgr3 |
Immune-related |
| FcRn-HU |
NM-HU-00109 |
Fcgrt |
cancer research,Immunotherapy,drug screening |
| R26-(hFcRn) |
NM-KI-00081 |
FCGRT |
cancer research；Immunotherapy,drug screening |
| Fcgrt-KO |
NM-KO-00133 |
Fcgrt |
Immunotherapy,drug screening |
| Fcrl5-KO |
NM-KO-190081 |
Fcrl5 |
Immune-related |
| R26-Fen1 |
NM-KI-00126 |
Fen1 |
|
| Fgf21-KO |
NM-KO-190275 |
Fgf21 |
Immune-related |
| Fgf21-CKO |
NM-CKO-00136 |
Fgf21 |
|
| R26-(CAG-LSL-FGFR2(K659N)-IRES-Luciferase-2A-EGFP) |
NM-KI-190078 |
FGFR2 |
cancer research |
| R26-(CAG-LSL-FGFR2(S320C)-IRES-Luciferase-2A-EGFP) |
NM-KI-190079 |
FGFR2 |
cancer research |
| R26-(CAG-LSL-FGFR2(W290C)-IRES-Luciferase-2A-EGFP) |
NM-KI-190080 |
FGFR2 |
cancer research |
| R26-(CAG-LSL-FGFR3(K562E)-IRES-Luciferase-2A-EGFP) |
NM-KI-190081 |
FGFR3 |
cancer research |
| R26-(CAG-LSL-FGFR3(S249C)-IRES-Luciferase-2A-EGFP) |
NM-KI-190082 |
FGFR3 |
cancer research |
| R26-(CAG-LSL-FGFR3-IRES-Luciferase-2A-EGFP) |
NM-KI-190083 |
FGFR3 |
cancer research |
| Fkbp5-KO |
NM-KO-190276 |
Fkbp5 |
Immune-related |
| Flt3-KO |
NM-KO-190082 |
Flt3 |
Immune-related |
| Fmod-KO |
NM-KO-190277 |
Fmod |
Immune-related |
| Fndc5-KO |
NM-KO-190278 |
Fndc5 |
Immune-related |
| Fos-(2A-tdTomato） |
NM-KI-190048 |
Fos |
fluorescent reporter mice |
| Fos-(2A-Venus-luci） |
NM-KI-190049 |
Fos |
fluorescent reporter mice |
| Fos-KO |
NM-KO-190083 |
Fos |
Immune-related |
| Fos-(Venus-Luci) |
NM-KI-18044 |
Fos |
|
| Foxl1-CreERT2 |
NM-KI-00135 |
Foxl1 |
|
| Foxn1-KO(M-NSG) |
NM-KO-190422 |
Foxn1 |
Immune-related,immunodeficiency,immune system,transplantation research |
| Foxn1-KO |
NM-KO-00052 |
Foxn1 |
immune system |
| Foxo3-KO |
NM-KO-190084 |
Foxo3 |
Immune-related |
| Foxp3-(IRES-DTREGFP） |
NM-KI-190046 |
Foxp3 |
DTR mouse |
| Foxp3-(V5-Avi tag-IRES-luci-2A-tdTomato) |
NM-KI-18034 |
Foxp3 |
gene tracing |
| Fst-KO |
NM-KO-190279 |
Fst |
Immune-related |
| Fto-CKO |
NM-CKO-190005 |
Fto |
Epigenetic |
| R26-(CAG-LSL-3xFLAG-Fto-IRES-EGFP) |
NM-KI-190055 |
Fto |
mRNA methylation |
| Gaa-KO |
NM-KO-190085 |
Gaa |
Immune-related |
| Gal-KO |
NM-KO-190086 |
Gal |
Immune-related |
| Ganab-KO |
NM-KO-190280 |
Ganab |
Immune-related |
| Garnl3-CKO |
NM-CKO-00007 |
Garnl3 |
|
| Gast-KO |
NM-KO-190087 |
Gast |
Immune-related |
| Gba-(D427V) |
NM-KI-18060 |
Gba |
|
| Gdi2-KO |
NM-KO-190281 |
Gdi2 |
Immune-related |
| Gfap-(IRES-Venus-Luciferase) |
NM-KI-190022 |
Gfap |
nervous system |
| Col1a1-e(TetO-GFPCre-M2rtTA) |
NM-KI-18014 |
GFPCre |
Cre recombinase tool |
| R26-(SA-RNR-GFPDTR-FWF-pA) |
NM-KI-18013 |
GFPDTR |
GFPDTR tool mice |
| Ghsr-KO |
NM-KO-00007 |
Ghsr |
digestive system,metabolism |
| Gjc3-KO |
NM-KO-190282 |
Gjc3 |
Immune-related |
| Gkn2-CKO |
NM-CKO-00080 |
Gkn2 |
homeostasis/metabolism |
| Glyat-KO |
NM-KO-190088 |
Glyat |
Immune-related |
| Gpam-KO |
NM-KO-190283 |
Gpam |
Immune-related |
| Gpr1-KO |
NM-KO-00057 |
Gpr1 |
|
| Gpr142-KO |
NM-KO-00058 |
Gpr142 |
|
| Gpr152-KO |
NM-KO-190284 |
Gpr152 |
Immune-related |
| Gpr156-CKO |
NM-CKO-00099 |
Gpr156 |
|
| Gpr160-KO |
NM-KO-00061 |
Gpr160 |
|
| Gpr183-KO |
NM-KO-190285 |
Gpr183 |
Immune-related |
| Gpr26-KO |
NM-KO-00053 |
Gpr26 |
immune system |
| Gpr61-KO |
NM-KO-00060 |
Gpr61 |
|
| Gpr83-KO |
NM-KO-190090 |
Gpr83 |
Immune-related |
| Gpr89-Prkab2-KO |
NM-KO-18055 |
Gpr89，Prkab2 |
|
| Gprc6a-CKO |
NM-CKO-00098 |
Gprc6a |
nervous system |
| Grpr-KO |
NM-KO-190286 |
Grpr |
Immune-related |
| Gsdmd-CKO |
NM-CKO-190060 |
Gsdmd |
cell pyroptosis,cell apoptosis |
| R26-(CAG-LSL-HA-GiDREADD（hM4Di）-mCitrine) |
NM-KI-190093 |
Gt(ROSA)26Sor |
Chemical Genetics studies.The inhibitory GiDREADD(hM4Di) could silence the activity of neurons following administration of CNO. |
| R26-(SA-2xpA-CAG-EGFP) |
NM-KI-190088 |
Gt(ROSA)26Sor |
Reporter mice, EGFP |
| R26-(CAG-EGFP)1 |
NM-KI-190089 |
Gt(ROSA)26Sor |
Reporter mice, EGFP |
| R26-(CAG-EGFP)2 |
NM-KI-190090 |
Gt(ROSA)26Sor |
Reporter mice, EGFP |
| R26-(Alb-NTCP-C9 tag-IRES-EGFP) |
NM-KI-190021 |
Gt(ROSA)26Sor |
HBV |
| R26-(CAG-LSL-3xFLAG-Mettl14-IRES-EGFP) |
NM-KI-190017 |
Gt(ROSA)26Sor |
mRNA methylation |
| R26-(CAG-LSL-3xFLAG-Ythdf2-IRES-EGFP) |
NM-KI-190018 |
Gt(ROSA)26Sor |
mRNA methylation |
| R26-(TetO-Dre-IRES-BFP) |
NM-KI-190020 |
Gt(ROSA)26Sor |
Dre recombinase tool |
| R26-(CAG-LSL-Avi-EGFP-Rpl10a) |
NM-KI-190005 |
Gt(ROSA)26Sor |
ribosome |
| R26-(CAG-LSL-EGFR-del19) |
NM-KI-190004 |
Gt(ROSA)26Sor |
cancer research |
| R26-(CAG-LSL-FGFR2-luciferase-EGFP) |
NM-KI-190007 |
Gt(ROSA)26Sor |
cancer |
| R26-(CAG-LSL-HER2-luciferase-EGFP) |
NM-KI-190008 |
Gt(ROSA)26Sor |
cancer |
| R26-(CAG-LSL-EGFR T790M-del19-luciferase-tdTomato) |
NM-KI-190009 |
Gt(ROSA)26Sor |
cancer |
| R26-(CAG-LSL-EML4-ALK(F1174L)-luciferase-tdTomato) |
NM-KI-190010 |
Gt(ROSA)26Sor |
cancer |
| R26-(Alb-TK-luc-EGFP) |
NM-KI-18040 |
Gt(ROSA)26Sor |
|
| R26-(SA-EGFP-polyA) |
NM-KI-18024 |
Gt(ROSA)26Sor |
Reporter mice,EGFP |
| R26-(Luc-EGFP) |
NM-KI-00087 |
Gt(ROSA)26Sor |
gene tracing |
| R26-(Renilla-Luc) |
NM-KI-00091 |
Gt(ROSA)26Sor |
|
| R26-(PB-V5) |
NM-KI-00065 |
Gt(ROSA)26Sor |
gene editing, gene modification |
| R26-(PhiC31) |
NM-KI-00088 |
Gt(ROSA)26Sor |
|
| R26-(CaMPARI) |
NM-KI-00090 |
Gt(ROSA)26Sor |
nervous system |
| Gzma-KO |
NM-KO-190188 |
Gzma |
Immune-related |
| Gzmb-KO |
NM-KO-190091 |
Gzmb |
Immune-related |
| H19-KO |
NM-KO-18045 |
H19 |
H19 gene function |
| H2-Ab1/H2-Ea-ps-KO(M-NSG) |
NM-NSG-003 |
H2-Ab1，H2-Ea-ps |
immunodeficiency,immune system,transplantation research |
| H2-Ab1/H2-Ea-ps-KO(Nod-Scid) |
NM-KO-18057 |
H2-Ab1，H2-Ea-ps |
immune system |
| H2-Ab1/H2-Ea-ps-KO |
NM-KO-18032 |
H2-Ab1，H2-Ea-ps |
immune system |
| Havcr2-KO |
NM-KO-18049 |
Havcr2 |
|
| TIM3-HU |
NM-HU-00054 |
Havcr2 |
Immunotherapy,cancer research,drug screening |
| Hbp1-KO |
NM-KO-190092 |
Hbp1 |
Immune-related |
| Hc-KO |
NM-KO-190191 |
Hc |
Immune-related |
| Hdac10-CKO |
NM-CKO-00127 |
Hdac10 |
cancer research |
| Hdac11-KO |
NM-KO-00086 |
Hdac11 |
immune system,HDAC gene function research, epigenetic research, etc. |
| Hdac2-CKO |
NM-CKO-00123 |
Hdac2 |
|
| Hdac4-KO |
NM-KO-00075 |
Hdac4 |
cancer research,HDAC function study, epigenetic research |
| Hdac5-CKO |
NM-CKO-00132 |
Hdac5 |
cancer research |
| Hdac6-CKO |
NM-CKO-18013 |
Hdac6 |
|
| Hdac6-KO |
NM-KO-18009 |
Hdac6 |
HDAC gene function research, epigenetic research, etc. |
| Hdac9-CKO |
NM-CKO-00125 |
Hdac9 |
|
| Hebp1-CKO |
NM-CKO-00137 |
Hebp1 |
|
| Hes2-KO |
NM-KO-190287 |
Hes2 |
Immune-related |
| Hif1an-KO |
NM-KO-190288 |
Hif1an |
Immune-related |
| Hint2-CKO |
NM-CKO-00086 |
Hint2 |
|
| Hnf4a-CKO |
NM-CKO-190062 |
Hnf4a |
Transcriptional regulator, insulin secretion related |
| Hopx-(2A-DreERT2） |
NM-KI-190035 |
Hopx |
Dre recombinase tool |
| Hoxb5-(2A-tdTomato） |
NM-KI-190047 |
Hoxb5 |
fluorescent reporter mice |
| Hpse-KO |
NM-KO-190289 |
Hpse |
Immune-related |
| Hspa13-CKO |
NM-CKO-00092 |
Hspa13 |
nervous system，neurological，vestibular，aging related research |
| Htr4-KO |
NM-KO-190290 |
Htr4 |
Immune-related |
| ICOS-HU |
NM-HU-190030 |
Icos |
Immunotherapy,cancer research,drug screening |
| Icos-KO |
NM-KO-190093 |
Icos |
Immune-related |
| ICOS&ICOSL-HU |
NM-HU-18018 |
Icos，Icosl |
Immunotherapy,cancer research,drug screening |
| ICOS-HU |
NM-HU-00052 |
Icos |
Immunotherapy,cancer research,drug screening |
| ICOSL-HU |
NM-HU-00095 |
Icosl |
Immunotherapy,cancer research,drug screening |
| R26-(CAG-LSL-IDH1(R132H)-IRES-Luciferase-2A-tdTomato) |
NM-KI-190074 |
IDH1 |
cancer research |
| R26-(CAG-LSL-IDH2(R140Q)-IRES-Luciferase-2A-tdTomato) |
NM-KI-190075 |
IDH2 |
cancer research |
| R26-(CAG-LSL-IDH2(R172K)-IRES-Luciferase-2A-tdTomato) |
NM-KI-190076 |
IDH2 |
cancer research |
| PD-1&PD-L1&IDO1-HU |
NM-HU-00120 |
Ido1，Pdcd1，Cd274 |
cancer research,Immunotherapy,drug screening |
| IDO1-HU |
NM-HU-00061 |
Ido1 |
Immunotherapy,cancer research,drug screening |
| Ifi44-KO |
NM-KO-190094 |
Ifi44 |
Immune-related |
| Ifih1-KO |
NM-KO-190225 |
Ifih1 |
Immune-related |
| Ifnar1-KO |
NM-KO-18038 |
Ifnar1 |
immune system |
| Ifnar2-KO |
NM-KO-190291 |
Ifnar2 |
Immune-related |
| Ifng-(Venus-Luci) |
NM-KI-18041 |
Ifng |
|
| Ifngr1-KO |
NM-KO-190432 |
Ifngr1 |
immune system |
| Ifngr1-KO |
NM-KO-18020 |
Ifngr1 |
immune system |
| Ifngr1&Ifnar1-KO |
NM-KO-190425 |
Ifngr1；Ifnar1 |
immune system |
| Ighm-KO |
NM-KO-18024 |
Ighm |
immune system,immunodeficiency |
| Ikzf4-KO |
NM-KO-190096 |
Ikzf4 |
Immune-related |
| Il10-KO |
NM-KO-190426 |
Il10 |
immune system |
| Il11-KO |
NM-KO-190293 |
Il11 |
Immune-related |
| Il11-(Luc-EGFP) |
NM-KI-00036 |
Il11 |
Inflammation and immunity, gene tracing |
| Il12a-(Luc-EGFP) |
NM-KI-00024 |
Il12a |
Inflammation and immunity, gene tracing |
| Il12b-(Luc-EGFP) |
NM-KI-00025 |
Il12b |
Inflammation and immunity, gene tracing |
| Il12rb1-KO |
NM-KO-190294 |
Il12rb1 |
Immune-related |
| Il13-KO |
NM-KO-00124 |
Il13 |
immune system |
| Il15-(Luc-EGFP) |
NM-KI-00027 |
Il15 |
Inflammation and immunity, gene tracing |
| Il16-(Luc-EGFP) |
NM-KI-00028 |
Il16 |
Inflammation and immunity, gene tracing |
| IL17A-HU |
NM-HU-00042 |
Il17a |
Immunotherapy,cancer research,drug screening |
| Il17a-(CreERT2) |
NM-KI-00059 |
Il17a |
Immune system |
| Il17a-KO |
NM-KO-00131 |
Il17a |
immune system |
| Il17b-(Luc-EGFP) |
NM-KI-00029 |
Il17b |
Inflammation and immunity, gene tracing |
| Il17c-(Luc-EGFP) |
NM-KI-00030 |
Il17c |
Inflammation and immunity, gene tracing |
| IL17F-HU |
NM-HU-190007 |
Il17f |
Immune-related |
| Il17f-(Luc-EGFP) |
NM-KI-00031 |
Il17f |
Inflammation and immunity, gene tracing |
| IL17RA-HU |
NM-HU-190049 |
Il17ra |
Immunotherapy,cancer research,drug screening |
| Il17re-KO |
NM-KO-190295 |
Il17re |
Immune-related |
| Il18-(Luc-EGFP) |
NM-KI-00032 |
Il18 |
Inflammation and immunity, gene tracing |
| Il19-(Luc-EGFP) |
NM-KI-00033 |
Il19 |
Inflammation and immunity, gene tracing |
| Il1a-(Luc-EGFP) |
NM-KI-00009 |
Il1a |
Inflammation and immunity, gene tracing |
| IL1B-HU |
NM-HU-190047 |
Il1b |
Immunotherapy,cancer research,drug screening |
| Il1b-(Luc-EGFP) |
NM-KI-00010 |
Il1b |
Inflammation and immunity,gene tracing |
| Il1b-Luc |
NM-TG-00001 |
Il1b |
anti-inflammatory,inflammatory process |
| Il1f10-(Luc-EGFP) |
NM-KI-00060 |
Il1f10 |
Inflammation and immunity, gene tracing |
| Il1f10-KO |
NM-KO-00103 |
Il1f10 |
immune system |
| Il1f6-KO |
NM-KO-00097 |
Il1f6 |
immune system |
| Il1f6-(Luc-EGFP) |
NM-KI-00017 |
Il1f6 |
Inflammation and immunity, gene tracing |
| Il1f9-(Luc-EGFP) |
NM-KI-00018 |
Il1f9 |
Inflammation and immunity, gene tracing |
| Il1rap-KO |
NM-KO-190445 |
Il1rap |
Cancer Research, Immunology, Inflammation and Autoimmunity Research. Alzheimer's disease related |
| Il1rl1-KO |
NM-KO-190296 |
Il1rl1 |
Immune-related |
| IL2-HU |
NM-HU-190048 |
Il2 |
Immunotherapy,cancer research,drug screening |
| Il2-(Venus-Luci) |
NM-KI-18057 |
Il2 |
Gene tracing |
| Il2-CKO |
NM-CKO-00108 |
Il2 |
|
| Il21-KO |
NM-KO-18040 |
IL21 |
immune system |
| IL23A-HU |
NM-HU-18030 |
Il23a |
Immunotherapy,Cancer research,Drug screening |
| Il23a-(Luc-EGFP) |
NM-KI-00057 |
Il23a |
Inflammation and immunity, gene tracing |
| Il23r-KO |
NM-KO-190097 |
Il23r |
Immune-related |
| Il25-KO |
NM-KO-00113 |
Il25 |
immune system |
| Il2ra-KO |
NM-KO-190098 |
Il2ra |
Immune-related |
| M-NSG |
NM-NSG-001 |
Il2rg |
Immune and hematopoietic research |
| IL3-HU |
NM-HU-190045 |
Il3 |
Immunotherapy,cancer research,drug screening |
| IL3-HU |
NM-HU-190009 |
Il3 |
Immune-related |
| Il3-(Luc-EGFP) |
NM-KI-00020 |
Il3 |
Inflammation and immunity, gene tracing |
| Il33-KO |
NM-KO-190436 |
Il33 |
immune |
| Il33-KO |
NM-KO-00099 |
Il33 |
immune system |
| Il34-(Luc-EGFP) |
NM-KI-00035 |
Il34 |
Inflammation and immunity, gene tracing |
| Il4-(Luc-EGFP) |
NM-KI-00021 |
Il4 |
Inflammation and immunity, gene tracing |
| IL4RA-HU |
NM-HU-190008 |
Il4ra |
Immune-related |
| Il5-HU |
NM-HU-190001 |
Il5 |
Immune-related |
| Il5-(Luc-EGFP) |
NM-KI-00022 |
Il5 |
Inflammation and immunity, gene tracing |
| IL5RA-HU |
NM-HU-190055 |
Il5ra |
Immunotherapy,cancer research,drug screening |
| IL6&IL6R-HU |
NM-HU-190025 |
Il6，Il6ra |
Immune-related |
| Il6-KO |
NM-KO-18029 |
Il6 |
immune system,immunodeficiency |
| Il6-(Luc-EGFP) |
NM-KI-00011 |
Il6 |
Inflammation and immunity,gene tracing |
| Il6ra-KO |
NM-KO-18042 |
Il6ra |
inflammatory, immune system |
| IL6R-HU |
NM-HU-00044 |
Il6ra |
Immunotherapy,cancer research,drug screening |
| IL7-HU |
NM-HU-190031 |
Il7 |
Immunotherapy,cancer research,drug screening |
| Il7-(Luc-EGFP) |
NM-KI-00092 |
Il7 |
Inflammation and immunity, gene tracing |
| Il7-KO |
NM-KO-00098 |
Il7 |
immune system |
| IL9-HU |
NM-HU-18029 |
Il9 |
Immunotherapy,Cancer research,Drug screening |
| Il9-(Luc-EGFP) |
NM-KI-00023 |
Il9 |
Immune system |
| Ildr2-KO |
NM-KO-18034 |
Ildr2 |
Metabolism, endocrine |
| Inpp4b-KO |
NM-KO-190297 |
Inpp4b |
Immune-related |
| Ins2-(DreERT2） |
NM-KI-190039 |
Ins2 |
Dre recombinase tool |
| Irak1-KO |
NM-KO-190298 |
Irak1 |
Immune-related |
| Irf1-KO |
NM-KO-190099 |
Irf1 |
Immune-related |
| Irf4-KO |
NM-KO-190100 |
Irf4 |
Immune-related |
| Irf8-KO |
NM-KO-190101 |
Irf8 |
Immune-related |
| Isl1-(CreERT2) |
NM-KI-00013 |
Isl1 |
Cre recombinase tool |
| Itgax-(2A-DreERT2） |
NM-KI-190032 |
Itgax |
Dre recombinase tool |
| Itgax-(IRES-DTREGFP） |
NM-KI-190043 |
Itgax |
DTR mouse |
| Itgbl1-KO |
NM-KO-190299 |
Itgbl1 |
Immune-related |
| Itk-KO |
NM-KO-190102 |
Itk |
Immune-related |
| R26-(CAG-LSL-Itpr1-Flag-tdTomato) |
NM-KI-18046 |
Itpr1 |
|
| Jmy-CKO |
NM-CKO-00022 |
Jmy |
|
| Jtb-KO |
NM-KO-190300 |
Jtb |
Immune-related |
| Kank1-(2A-DreERT2） |
NM-KI-190040 |
Kank1 |
Dre recombinase tool |
| Kat2a-CKO |
NM-CKO-190023 |
Kat2a |
Epigenetic |
| Kat6b-CKO |
NM-CKO-190024 |
Kat6b |
Epigenetic |
| Kcp-KO |
NM-KO-190301 |
Kcp |
Immune-related |
| Kctd20-KO |
NM-KO-190302 |
Kctd20 |
Immune-related |
| Kdm1a-CKO |
NM-CKO-190025 |
Kdm1a |
Epigenetic |
| Kdm3a-CKO |
NM-CKO-190026 |
Kdm3a |
Epigenetic |
| Kdm4b-KO |
NM-KO-190303 |
Kdm4b |
Immune-related |
| Kdm4d-KO |
NM-KO-190304 |
Kdm4d |
Immune-related |
| Kdm5a-CKO |
NM-CKO-190027 |
Kdm5a |
Epigenetic |
| Kdm5a-KO |
NM-KO-190305 |
Kdm5a |
Immune-related |
| Kdm6a-CKO |
NM-CKO-190054 |
Kdm6a |
Epigenetic |
| Kdr-HU |
NM-HU-00098 |
Kdr |
Immunotherapy,cancer research,drug screening |
| kif18A-KO |
NM-KO-00008 |
kif18A |
male infertility，orchiatrophy，azoospermia |
| Kit-(V831M) |
NM-KI-190023 |
Kit |
hematopoieticstem cell |
| Klb-CKO |
NM-CKO-00135 |
Klb |
|
| Klf14-KO |
NM-KO-190306 |
Klf14 |
Immune-related |
| Klf9-KO |
NM-KO-190307 |
Klf9 |
Immune-related |
| Klrc1-KO |
NM-KO-190126 |
Klrc1 |
Immune-related |
| Klrg1-KO |
NM-KO-190103 |
Klrg1 |
Immune-related |
| KLRK1-HU |
NM-HU-190005 |
Klrk1 |
Immune-related |
| Kmt2a-CKO |
NM-CKO-190028 |
Kmt2a |
Epigenetic |
| Kmt2b-CKO |
NM-CKO-190029 |
Kmt2b |
Epigenetic |
| Kmt2d-CKO |
NM-CKO-190030 |
Kmt2d |
Epigenetic |
| Kpna2-KO |
NM-KO-190308 |
Kpna2 |
Immune-related |
| Kras-(LSL-G12D) |
NM-KI-190003 |
Kras |
cancer research |
| Krt14-(CreERT2) |
NM-KI-190024 |
Krt14 |
Cre recombinase tool |
| Krt14-KO |
NM-KO-00072 |
Krt14 |
skin |
| Krt5-(2A-CreERT2) |
NM-KI-190016 |
Krt5 |
Cre recombinase tool |
| Kynu-CKO |
NM-CKO-00059 |
Kynu |
|
| LAG3&CTLA4-HU |
NM-HU-190018 |
Lag3，Ctla4 |
Immune-related |
| Lag3-KO |
NM-KO-18048 |
Lag3 |
|
| LAG3-HU |
NM-HU-00049 |
Lag3 |
Immunotherapy,cancer research,drug screening |
| Lap3-KO |
NM-KO-190104 |
Lap3 |
Immune-related |
| Layn-KO |
NM-KO-190105 |
Layn |
Immune-related |
| Lcn2-CKO |
NM-CKO-00134 |
Lcn2 |
|
| Lcn6-CKO |
NM-CKO-00109 |
Lcn6 |
Androgen Insensitivity Syndrome（AIS）,Obesity，Diabetes Mellitus,Noninsulin-Dependent（NIDDM）,Prostate Cancer |
| Ldlr-(T541C) |
NM-KI-00043 |
Ldlr |
Metabolic and cardiovascular disease research |
| Ldlr-KO |
NM-KO-00102 |
Ldlr |
Cardiovascular research; lipid metabolism related research |
| Lep-KO |
NM-KO-00034 |
Lep |
Insulin resistance,obesity,and type 2 diabetes etc. |
| Lepr-(109052G>T) |
NM-KI-00001 |
Lepr |
Leptin resistance,insulin resistance,obesity,and type 2 diabetes etc. |
| Lgals1-KO |
NM-KO-190106 |
Lgals1 |
Immune-related |
| Lgals3-KO |
NM-KO-190107 |
Lgals3 |
Immune-related |
| Lgals3bp-KO |
NM-KO-190309 |
Lgals3bp |
Immune-related |
| Lgmn-CKO |
NM-CKO-00103 |
Lgmn |
cardiovascular system，nervous system，Developmental Biology |
| Lif-KO |
NM-KO-190108 |
Lif |
Immune-related |
| Lor-KO |
NM-KO-190109 |
Lor |
Immune-related |
| Lpo-KO |
NM-KO-190110 |
Lpo |
Immune-related |
| Lrrc32-KO |
NM-KO-190111 |
Lrrc32 |
Immune-related |
| Ltb4r2-KO |
NM-KO-190310 |
Ltb4r2 |
Immune-related |
| Ltf-CKO |
NM-CKO-00042 |
Ltf |
|
| Lum-KO |
NM-KO-190112 |
Lum |
Immune-related |
| Ly6a-(2A-iCre) |
NM-KI-190028 |
Ly6a |
Cre recombinase tool |
| Ly6g-(2A-DreERT2） |
NM-KI-190036 |
Ly6g |
Dre recombinase tool |
| Lyar-KO |
NM-KO-190311 |
Lyar |
Immune-related |
| Lyar-CKO |
NM-CKO-00032 |
Lyar |
|
| Lyg1-KO |
NM-KO-00017 |
Lyg1 |
|
| Lyl1-KO |
NM-KO-190113 |
Lyl1 |
Immune-related |
| Lyz1-(2A-DreERT2） |
NM-KI-190033 |
Lyz1 |
Dre recombinase tool |
| Lyz2-(IRES-DTREGFP） |
NM-KI-190041 |
Lyz2 |
DTR mouse |
| Lyz2-(CreERT2-EGFP) |
NM-KI-18047 |
Lyz2 |
Cre recombinase activity in myeloid cells |
| Lyz2-(2A-CreERT2-WPRE-pA) |
NM-KI-18018 |
Lyz2 |
Cre recombinase tool |
| Lyzl4-KO |
NM-KO-00006 |
Lyzl4 |
Reproductive system related research |
| H11-(CAG-LSL-M2rtTA-FRT-IRES-tdtomato-FRT) |
NM-KI-190064 |
M2rtTA |
tetracycline,M2rtTA mice |
| Macrod2-CKO |
NM-CKO-190058 |
Macrod2 |
Cancer |
| Mal-KO |
NM-KO-00037 |
Mal |
nervous system |
| R26-(CAG-LSL-mCherry-EGFP-LC3-pA) |
NM-KI-00124 |
Map1lc3a |
|
| Map2-(CreERT2) |
NM-KI-00037 |
Map2 |
Cre recombinase tool of mature neurons,nervous system |
| Map3k9-KO |
NM-KO-190317 |
Map3k9 |
Immune-related |
| Mavs-KO |
NM-KO-190198 |
Mavs |
Immune-related |
| Mbd1-CKO |
NM-CKO-190031 |
Mbd1 |
Epigenetic |
| Mbd2-KO |
NM-KO-190114 |
Mbd2 |
Immune-related |
| Mbd3-CKO |
NM-CKO-190049 |
Mbd3 |
Epigenetic |
| Mbd5-CKO |
NM-CKO-00035 |
Mbd5 |
|
| Mbp-KO |
NM-KO-190115 |
Mbp |
Immune-related |
| Mcam-KO |
NM-KO-190312 |
Mcam |
Immune-related |
| Mdm4-(C462A) |
NM-KI-00007 |
Mdm4 |
|
| Mecp2-CKO |
NM-CKO-190001 |
Mecp2 |
Rett syndrome, autism |
| Megf9-KO |
NM-KO-190313 |
Megf9 |
Immune-related |
| Mettl14-CKO |
NM-CKO-190007 |
Mettl14 |
Epigenetic |
| Mettl16-KO |
NM-KO-190314 |
Mettl16 |
Immune-related |
| Mettl21a-KO |
NM-KO-190315 |
Mettl21a |
Immune-related |
| Mettl3-CKO |
NM-CKO-190006 |
Mettl3 |
Epigenetic |
| R26-(CAG-LSL-3xFLAG-Mettl3-IRES-EGFP) |
NM-KI-190056 |
Mettl3 |
mRNA methylation |
| Mid1-KO |
NM-KO-190316 |
Mid1 |
Immune-related |
| Mip-KO |
NM-KO-190116 |
Mip |
Immune-related |
| Mir125a-KO |
NM-KO-00040 |
Mir125a |
|
| Mir126-CKO |
NM-CKO-00030 |
Mir126 |
|
| Mir21a-KO |
NM-KO-00159 |
Mir21a |
microRNA |
| Mir21a-CKO |
NM-CKO-00051 |
Mir21a |
|
| Mir29a-Mir29b1-KO |
NM-KO-00081 |
Mir29a，Mir29b-1 |
microRNA,mir29 gene function study |
| Mir29b2-Mir29c-KO |
NM-KO-00080 |
Mir29b-2，Mir29c |
microRNA,Mir29 gene function study |
| Mirc34-KO |
NM-KO-00164 |
Mir449a，Mir449b，Mir449c |
microRNA |
| Mlc1-KO |
NM-KO-190117 |
Mlc1 |
Immune-related |
| Mog-KO |
NM-KO-190118 |
Mog |
Immune-related |
| Mptx1-KO |
NM-KO-190318 |
Mptx1 |
Immune-related |
| Mr1-KO |
NM-KO-190119 |
Mr1 |
Immune-related |
| Mrc1-KO |
NM-KO-190228 |
Mrc1 |
Immune-related |
| Mrc2-KO |
NM-KO-190216 |
Mrc2 |
Immune-related |
| Mreg-KO |
NM-KO-190121 |
Mreg |
Immune-related |
| Mrgprf-KO |
NM-KO-00050 |
Mrgprf |
|
| Mt1-KO |
NM-KO-00161 |
Mt1 |
Antioxidation, intracellular metal homeostasis, oxidative stress |
| Mtnr1b-KO |
NM-KO-190319 |
Mtnr1b |
Immune-related |
| Mtrex-KO |
NM-KO-190370 |
Mtrex |
Immune-related |
| Muc1-KO |
NM-KO-190120 |
Muc1 |
Immune-related |
| Muc1-CKO |
NM-CKO-00061 |
Muc1 |
|
| Mxd4-KO |
NM-KO-190320 |
Mxd4 |
Immune-related |
| H11-(Myc) |
NM-KI-00039 |
Myc |
tumor-bearing model,cancer research |
| H11-(CAG-LSL-HA tag-Nmyc-IRES-EGFP) |
NM-KI-190084 |
Mycn |
cancer research |
| Mycn-(TRE-EGFP) |
NM-KI-00008 |
Mycn |
cancer research, nervous system research |
| Myd88-KO |
NM-KO-190192 |
Myd88 |
Immune-related |
| Mydgf-CKO |
NM-CKO-00021 |
Mydgf |
|
| Myh11-(2A-DreERT2） |
NM-KI-190037 |
Myh11 |
Dre recombinase tool |
| Myh6-(Cre) |
NM-KI-00083 |
Myh6 |
Cre recombinase tool of heart |
| Myom2-KO |
NM-KO-190321 |
Myom2 |
Immune-related |
| Naa20-KO |
NM-KO-190322 |
Naa20 |
Immune-related |
| Naalad2-KO |
NM-KO-00039 |
Naalad2 |
|
| Naip1-KO |
NM-KO-190203 |
Naip1 |
Immune-related |
| Ncapg-KO |
NM-KO-190323 |
Ncapg |
Immune-related |
| Ncf1-KO |
NM-KO-190123 |
Ncf1 |
Immune-related |
| Ncoa2-CKO |
NM-CKO-190032 |
Ncoa2 |
Epigenetic |
| Ncoa3-CKO |
NM-CKO-190033 |
Ncoa3 |
Epigenetic |
| Ncr1-(2A-iCre） |
NM-KI-190027 |
Ncr1 |
Cre recombinase tool |
| Ncr1-(IRES-DTREGFP） |
NM-KI-190044 |
Ncr1 |
DTR mouse |
| Ndufs7-KO |
NM-KO-190324 |
Ndufs7 |
Immune-related |
| Nfatc2-KO |
NM-KO-190124 |
Nfatc2 |
Immune-related |
| R26-(CAG-LSL-NFE2L2(G81S)-IRES-Luciferase-2A-tdTomato) |
NM-KI-190077 |
NFE2L2 |
cancer research |
| Nfe2l2-KO |
NM-KO-190433 |
Nfe2l2 |
transcription factor |
| Nfil3-KO |
NM-KO-190125 |
Nfil3 |
Immune-related |
| R26-(CAG-LSL-NgAgo-IRES-EGFP-WPRE-pA) |
NM-KI-18011 |
NgAgo |
|
| Nipbl-CKO |
NM-CKO-00067 |
Nipbl |
nervous system |
| Nkg7-KO |
NM-KO-190127 |
Nkg7 |
Immune-related |
| Nkx3-1-(CreERT2) |
NM-KI-18036 |
Nkx3-1 |
Cre recombinase tool |
| Nlrc3-KO |
NM-KO-190220 |
Nlrc3 |
Immune-related |
| Nlrc4-KO |
NM-KO-190226 |
Nlrc4 |
Immune-related |
| Nlrc5-KO |
NM-KO-00042 |
Nlrc5 |
immune system |
| Nlrp10-KO |
NM-KO-190199 |
Nlrp10 |
Immune-related |
| Nlrp12-KO |
NM-KO-190200 |
Nlrp12 |
Immune-related |
| Nlrp14-KO |
NM-KO-190201 |
Nlrp14 |
Immune-related |
| Nlrp1a-KO |
NM-KO-190227 |
Nlrp1a |
Immune-related |
| Nlrp2-KO |
NM-KO-190206 |
Nlrp2 |
Immune-related |
| Nlrp3-CKO |
NM-CKO-190002 |
Nlrp3 |
Immune-related |
| Nlrp3-KO |
NM-KO-190428 |
Nlrp3 |
Immune-related |
| Nlrp3-KO |
NM-KO-190230 |
Nlrp3 |
Immune-related |
| Nlrp4c-KO |
NM-KO-190207 |
Nlrp4c |
Immune-related |
| Nlrp4e-KO |
NM-KO-190325 |
Nlrp4e |
Immune-related |
| Nlrp5-KO |
NM-KO-190209 |
Nlrp5 |
Immune-related |
| Nlrp6-KO |
NM-KO-190211 |
Nlrp6 |
Immune-related |
| Nmu-KO |
NM-KO-190326 |
Nmu |
Immune-related |
| Nod1-KO |
NM-KO-190208 |
Nod1 |
Immune-related |
| Nod2-KO |
NM-KO-190210 |
Nod2 |
Immune-related |
| Nos2-KO |
NM-KO-18027 |
Nos2 |
inflammatory |
| Nos3-KO |
NM-KO-18022 |
Nos3 |
|
| Notch3-KO |
NM-KO-190129 |
Notch3 |
Immune-related |
| Npb-KO |
NM-KO-190130 |
Npb |
Immune-related |
| Npc1-(I1060T) |
NM-KI-18059 |
Npc1 |
|
| Npffr2-KO |
NM-KO-190327 |
Npffr2 |
Immune-related |
| Nphs2-CreERT2 |
NM-KI-00128 |
Nphs2 |
|
| Npr3-(2A-DreERT2) |
NM-KI-190015 |
Npr3 |
Dre recombinase tool |
| Nr1h4-KO |
NM-KO-190328 |
Nr1h4 |
Immune-related |
| Nr2e1-KO |
NM-KO-00163 |
Nr2e1 |
|
| Nr6a1-CKO |
NM-CKO-00054 |
Nr6a1 |
|
| Nrip2-KO |
NM-KO-190329 |
Nrip2 |
Immune-related |
| Nsd1-CKO |
NM-CKO-190050 |
Nsd1 |
Epigenetic |
| Olr1-KO |
NM-KO-190330 |
Olr1 |
Immune-related |
| Oosp1-KO |
NM-KO-00030 |
Oosp1 |
|
| Orai1-KO |
NM-KO-190131 |
Orai1 |
Immune-related |
| Osbpl2-KO |
NM-KO-190331 |
Osbpl2 |
Immune-related |
| Otub2-KO |
NM-KO-190332 |
Otub2 |
Immune-related |
| Otud3-KO |
NM-KO-190333 |
Otud3 |
Immune-related |
| Padi4-KO |
NM-KO-190334 |
Padi4 |
Immune-related |
| Palld-KO |
NM-KO-00009 |
Palld |
Research on embryonic development, nervous system, hematopoietic system, etc. |
| Pappa-KO |
NM-KO-190132 |
Pappa |
Immune-related |
| Paqr4-KO |
NM-KO-00044 |
Paqr4 |
|
| Paqr4-CKO |
NM-CKO-00069 |
Paqr4 |
|
| Paqr9-KO |
NM-KO-00062 |
Paqr9 |
|
| Pcbp2-KO |
NM-KO-190336 |
Pcbp2 |
Immune-related |
| PCSK9-HU |
NM-HU-00075 |
Pcsk9 |
Immunotherapy,cancer research,drug screening |
| Pdap1-KO |
NM-KO-190337 |
Pdap1 |
Immune-related |
| Pdc-KO |
NM-KO-190133 |
Pdc |
Immune-related |
| PD-1&SEMA4D-HU |
NM-HU-190033 |
Pdcd1，Sema4d |
Immunotherapy,cancer research,drug screening |
| PD-1&CD40-HU |
NM-HU-190017 |
Pdcd1，Cd40 |
Immune-related |
| PD-1&SIRPA-HU |
NM-HU-190022 |
Pdcd1，Sirpa |
Immune-related |
| PD-1&TLR9-HU |
NM-HU-190023 |
Pdcd1，Tlr9 |
Immune-related |
| PD-1&PD-L1&LAG3-HU |
NM-HU-190028 |
Pdcd1，Cd274，Lag3 |
Immune-related |
| PD-1&TIGIT&TIM3-HU |
NM-HU-190029 |
Pdcd1，Tigit，Havcr2 |
Immune-related |
| PD-1&GITR-HU |
NM-HU-190014 |
Pdcd1，Tnfrsf18 |
Immune-related |
| Pdcd1-KO |
NM-KO-190423 |
Pdcd1 |
Immune-related |
| PD-1&CD3e-HU |
NM-HU-18021 |
Pdcd1，Cd3e |
Immunotherapy,cancer research,drug screening |
| PD-1&4-1BB-HU |
NM-HU-00136 |
Pdcd1，Tnfrsf9 |
Immunotherapy,cancer research,drug screening |
| PD-1&PD-L1-HU |
NM-HU-00100 |
Pdcd1，Cd274 |
Immunotherapy,cancer research,drug screening |
| PD-1&TIM3-HU |
NM-HU-00103 |
Pdcd1，Havcr2 |
Immunotherapy,cancer research,drug screening |
| PD-1&LAG3-HU |
NM-HU-00101 |
Pdcd1，Lag3 |
Immunotherapy,cancer research,drug screening |
| PD-1&TIGIT-HU |
NM-HU-00104 |
Pdcd1，Tigit |
Immunotherapy,cancer research,drug screening |
| PD-1&OX40-HU |
NM-HU-00108 |
Pdcd1，Tnfrsf4 |
cancer research,Immunotherapy,drug screening |
| PD-1&CTLA4-HU |
NM-HU-00079 |
Pdcd1，Ctla4 |
cancer research,Immunotherapy,drug screening |
| PD-1-HU |
NM-HU-00015 |
Pdcd1 |
Immunotherapy,cancer research,drug screening |
| Pdcd10-CKO |
NM-CKO-00079 |
Pdcd10 |
|
| PDCD1LG2-HU |
NM-HU-190050 |
Pdcd1lg2 |
Immunotherapy,cancer research,drug screening |
| Pde7a-KO |
NM-KO-190134 |
Pde7a |
Immune-related |
| Pdgfd-KO |
NM-KO-190338 |
Pdgfd |
Immune-related |
| Pdx1-(Avi-CreERT2) |
NM-KI-18042 |
Pdx1 |
|
| Pecam1-KO |
NM-KO-190339 |
Pecam1 |
Immune-related |
| Pf4-KO |
NM-KO-190135 |
Pf4 |
Immune-related |
| Pgam5-KO |
NM-KO-190340 |
Pgam5 |
Immune-related |
| Pgp-KO |
NM-KO-190136 |
Pgp |
Immune-related |
| Phf6-KO |
NM-KO-190341 |
Phf6 |
Immune-related |
| Pias2-KO |
NM-KO-190342 |
Pias2 |
Immune-related |
| Piezo1-(CreERT2) |
NM-KI-18048 |
Piezo1 |
Mechanically sensitive ion channel Cre tool mouse |
| Piezo2-KO |
NM-KO-190343 |
Piezo2 |
Immune-related |
| R26-(CAG-LSL-PIK3CA(H1047R)-IRES-luciferase-2A-tdTomato) |
NM-KI-190065 |
PIK3CA |
cancer research |
| Plce1-KO |
NM-KO-190344 |
Plce1 |
Immune-related |
| Plin1-(2A-DreERT2） |
NM-KI-190034 |
Plin1 |
Dre recombinase tool |
| Pmel-KO |
NM-KO-190137 |
Pmel |
Immune-related |
| Pnliprp1-KO |
NM-KO-00005 |
Pnliprp1 |
Diabetes and Obesity |
| Pnpla3-KO |
NM-KO-00051 |
Pnpla3 |
|
| Ppara-KO |
NM-KO-190345 |
Ppara |
Immune-related |
| Ppp1r13b-KO |
NM-KO-190346 |
Ppp1r13b |
Immune-related |
| Ppp2r5e-KO |
NM-KO-190347 |
Ppp2r5e |
Immune-related |
| Ppp6c-CKO |
NM-CKO-00115 |
Ppp6c |
|
| Prdm2-CKO |
NM-CKO-190034 |
Prdm2 |
Epigenetic |
| Prf1-KO |
NM-KO-190193 |
Prf1 |
Immune-related |
| Prkdc-Il2rg-KO |
NM-KO-00158 |
Prkdc，Il2rg |
Immune and cancer research,drug screening |
| Prkdc-KO |
NM-KO-00105 |
Prkdc |
Immune and hematopoietic research |
| Prkn-KO |
NM-KO-190335 |
Prkn |
Immune-related |
| Prmt1-CKO |
NM-CKO-190051 |
Prmt1 |
Epigenetic |
| Prmt2-CKO |
NM-CKO-190035 |
Prmt2 |
Epigenetic |
| Prmt3-KO |
NM-KO-190348 |
Prmt3 |
Immune-related |
| Prmt7-KO |
NM-KO-190349 |
Prmt7 |
Immune-related |
| Procr-(2A-tdTomato) |
NM-KI-190051 |
Procr |
fluorescent reporter mice |
| Prrt2-CKO |
NM-CKO-00140 |
Prrt2 |
|
| Prrx1-KO |
NM-KO-00165 |
Prrx1 |
|
| Prrx2-KO |
NM-KO-190350 |
Prrx2 |
Immune-related |
| Prss29-CKO |
NM-CKO-00087 |
Prss29 |
Metabolism of proteins,nervous system development |
| Prss37-KO |
NM-KO-00016 |
Prss37 |
genital system |
| Prss54-KO |
NM-KO-00014 |
Prss54 |
genital system |
| Prss55-KO |
NM-KO-00013 |
Prss55 |
genital system |
| Ptch1-CKO |
NM-CKO-18015 |
Ptch1 |
|
| Pten-CKO |
NM-CKO-18004 |
Pten |
|
| Pten-KO |
NM-KO-18002 |
Pten |
cancer research |
| Ptgis-KO |
NM-KO-190351 |
Ptgis |
Immune-related |
| Pvalb-KO |
NM-KO-190352 |
Pvalb |
Immune-related |
| PVR-HU |
NM-HU-190012 |
Pvr |
Immune-related |
| Pycr1-KO |
NM-KO-190353 |
Pycr1 |
Immune-related |
| R3hcc1-CKO |
NM-CKO-00019 |
R3hcc1 |
|
| Rab5a-KO |
NM-KO-190354 |
Rab5a |
Immune-related |
| Rab7-KO |
NM-KO-190355 |
Rab7 |
Immune-related |
| Rag1-KO |
NM-KO-00069 |
Rag1 |
Immunodeficiency,tumor-bearing model |
| Rag2-KO |
NM-KO-190429 |
Rag2 |
Immunodeficiency,tumor-bearing model |
| Rag2-KO |
NM-KO-00070 |
Rag2 |
Immunodeficiency,tumor-bearing model |
| R26-(CAG-LSL-Rap1gds1-IRES-EGFP) |
NM-KI-190085 |
Rap1gds1 |
premature aging disease Hutchinson-Gilford progeria syndrome (HGPS) |
| Rb1-CKO |
NM-CKO-18012 |
Rb1 |
cancer research, aging |
| Rbck1-KO |
NM-KO-190356 |
Rbck1 |
Immune-related |
| Rdh13-KO |
NM-KO-00024 |
Rdh13 |
nervous system,metabolism |
| Reg3b-CKO |
NM-CKO-00128 |
Reg3b |
cancer research |
| Reg4-KO |
NM-KO-190357 |
Reg4 |
Immune-related |
| Reg4-CKO |
NM-CKO-00025 |
Reg4 |
|
| Rel-KO |
NM-KO-190138 |
Rel |
Immune-related |
| Rela-KO |
NM-KO-190139 |
Rela |
Immune-related |
| Resp18-(V5) |
NM-KI-18019 |
Resp18 |
|
| Resp18-KO |
NM-KO-00022 |
Resp18 |
Aging,nervous system related research |
| Resp18-CKO |
NM-CKO-00083 |
Resp18 |
|
| Rest-CKO |
NM-CKO-00001 |
Rest |
Neurodegenerative diseases (such as Huntington's disease) |
| Rfpl4-KO |
NM-KO-190358 |
Rfpl4 |
Immune-related |
| Rgsl2-KO |
NM-KO-190360 |
Rgsl2 |
Immune-related |
| Rhbdf2-CKO |
NM-CKO-00073 |
Rhbdf2 |
immune system， |
| Ripk3-KO |
NM-KO-190140 |
Ripk3 |
Immune-related |
| Rnf19b-KO |
NM-KO-190361 |
Rnf19b |
Immune-related |
| Robo3-CKO |
NM-CKO-00093 |
Robo3 |
|
| Rorc-KO |
NM-KO-190141 |
Rorc |
Immune-related |
| Rp1-KO |
NM-KO-190142 |
Rp1 |
Immune-related |
| Rps5-CKO |
NM-CKO-00143 |
Rps5 |
|
| Rps6ka5-CKO |
NM-CKO-190036 |
Rps6ka5 |
Epigenetic |
| Rps6ka6-KO |
NM-KO-190362 |
Rps6ka6 |
Immune-related |
| Rragc-KO |
NM-KO-190363 |
Rragc |
Immune-related |
| Rsad2-KO |
NM-KO-190364 |
Rsad2 |
Immune-related |
| Tg-(CAG-rtTRKRAB) |
NM-TG-00007 |
rtTRKRAB |
|
| S100a10-KO |
NM-KO-190365 |
S100a10 |
Immune-related |
| S100a9-KO |
NM-KO-190143 |
S100a9 |
Immune-related |
| Samd12-KO |
NM-KO-18005 |
Samd12 |
|
| Samhd1-KO |
NM-KO-190144 |
Samhd1 |
Immune-related |
| Sdc3-KO |
NM-KO-190366 |
Sdc3 |
Immune-related |
| Selenos-KO |
NM-KO-190412 |
Selenos |
Immune-related |
| PSGL-1-HU |
NM-HU-00046 |
Selplg |
Immunotherapy,cancer research,drug screening |
| Sema3g-CKO |
NM-CKO-00068 |
Sema3g |
|
| SEMA4D-HU |
NM-HU-00117 |
Sema4d |
Immunotherapy,cancer research,drug screening |
| Setd2-CKO |
NM-CKO-00126 |
Setd2 |
|
| Setd4-KO |
NM-KO-190367 |
Setd4 |
Immune-related |
| Setdb1-CKO |
NM-CKO-190052 |
Setdb1 |
Epigenetic |
| Sftpc-(Avitag-IRES-V5-M2rtTA-WPRE-polyA) |
NM-KI-18043 |
Sftpc |
|
| Sftpc-(IRES-CreERT2) |
NM-KI-18020 |
Sftpc |
Cre recombinase tool |
| Sgk1-KO |
NM-KO-190145 |
Sgk1 |
Immune-related |
| Sh3rf2-KO |
NM-KO-190449 |
Sh3rf2 |
Autism |
| Sh3rf2-CKO |
NM-CKO-190057 |
Sh3rf2 |
Autism |
| Sidt2-CKO |
NM-CKO-00041 |
Sidt2 |
Glucose homeostasis,regulation of insulin secretion |
| SIGLEC15-HU |
NM-HU-190037 |
Siglec15 |
Immunotherapy,cancer research,drug screening |
| SIRPA&CD47&PD-1-HU |
NM-HU-190026 |
Sirpa，Cd47，Pdcd1 |
Immune-related |
| SIRPA&CD47-HU |
NM-HU-190019 |
Sirpa，Cd47 |
Immune-related |
| SIRPA-HU |
NM-HU-18015 |
Sirpa |
Immunotherapy,drug screening |
| SIRPA-HU |
NM-HU-00119 |
Sirpa |
Immunotherapy,cancer research,drug screening |
| Sirt1-CKO |
NM-CKO-190037 |
Sirt1 |
Epigenetic |
| Sirt2-CKO |
NM-CKO-190038 |
Sirt2 |
Epigenetic |
| Sirt3-CKO |
NM-CKO-190039 |
Sirt3 |
Epigenetic |
| Sirt3-KO |
NM-KO-190368 |
Sirt3 |
Immune-related |
| Sirt5-KO |
NM-KO-190369 |
Sirt5 |
Immune-related |
| Slamf1-KO |
NM-KO-190146 |
Slamf1 |
Immune-related |
| SLAMF7-HU |
NM-HU-18028 |
Slamf7 |
Immunotherapy,Cancer research,Drug screening |
| Slc10a1-KO |
NM-KO-190371 |
Slc10a1 |
Immune-related |
| Slc17a6-(CreERT2) |
NM-KI-190011 |
Slc17a6 |
Tool Mice |
| Slc22a1&Slc22a2-KO |
NM-KO-18014 |
Slc22a1，Slc22a2 |
|
| Slc25a23-KO |
NM-KO-190372 |
Slc25a23 |
Immune-related |
| Slc2a10-KO |
NM-KO-190373 |
Slc2a10 |
Immune-related |
| Slc45a2-KO |
NM-KO-190374 |
Slc45a2 |
Immune-related |
| Slc47a1-KO |
NM-KO-18006 |
Slc47a1 |
|
| Slc6a1-(S295L) |
NM-KI-190014 |
Slc6a1 |
nervous system,immune system |
| Slc6a1-KO |
NM-KO-00002 |
Slc6a1 |
nervous system,immune system |
| Slc6a11-KO |
NM-KO-00046 |
Slc6a11 |
nervous system |
| Slc6A12-KO |
NM-KO-00047 |
Slc6A12 |
immune system |
| Slc6a13-KO |
NM-KO-00048 |
Slc6a13 |
immune system |
| Slc7a2-KO |
NM-KO-190375 |
Slc7a2 |
Immune-related |
| Slc9a5-KO |
NM-KO-00049 |
Slc9a5 |
|
| Slco1b2-Slco1a5-KO |
NM-KO-18030 |
Slco1b2，Slco1a5 |
|
| Slco4a1-KO |
NM-KO-190376 |
Slco4a1 |
Immune-related |
| Sln-KO |
NM-KO-190147 |
Sln |
Immune-related |
| Smad3-KO |
NM-KO-190149 |
Smad3 |
Immune-related |
| Smad4-CKO |
NM-CKO-18011 |
Smad4 |
|
| Smad5-CKO |
NM-CKO-18017 |
Smad5 |
|
| Smarca2-CKO |
NM-CKO-190040 |
Smarca2 |
Epigenetic |
| Smarca4-CKO |
NM-CKO-190041 |
Smarca4 |
Epigenetic |
| Smarcb1-CKO |
NM-CKO-190042 |
Smarcb1 |
Epigenetic |
| Smarcc1-CKO |
NM-CKO-190053 |
Smarcc1 |
Epigenetic |
| Smyd3-KO |
NM-KO-190379 |
Smyd3 |
Immune-related |
| Snap25-CKO |
NM-CKO-00091 |
Snap25 |
|
| Snca-KO |
NM-KO-190380 |
Snca |
Immune-related |
| Snd1-KO |
NM-KO-190381 |
Snd1 |
Immune-related |
| Snx10-KO |
NM-KO-00035 |
Snx10 |
|
| Snx16-KO |
NM-KO-18016 |
Snx16 |
|
| Snx16-CKO |
NM-CKO-00058 |
Snx16 |
|
| Soat2-CKO |
NM-CKO-18009 |
Soat2 |
|
| Socs2-KO |
NM-KO-190148 |
Socs2 |
Immune-related |
| Socs3-KO |
NM-KO-190150 |
Socs3 |
Immune-related |
| Sod1-KO |
NM-KO-190151 |
Sod1 |
Immune-related |
| Sod3-KO |
NM-KO-190382 |
Sod3 |
Immune-related |
| Sox9-Flp |
NM-KI-00131 |
Sox9 |
recombinase tool |
| Spag11a-(Luc-EGFP) |
NM-KI-00071 |
Spag11a |
gene tracing |
| Spata19-KO |
NM-KO-00015 |
Spata19 |
|
| Spem2-KO |
NM-KO-190383 |
Spem2 |
Immune-related |
| Spink7-KO |
NM-KO-190384 |
Spink7 |
Immune-related |
| Spns2-KO |
NM-KO-190385 |
Spns2 |
Immune-related |
| Srsf10-CKO |
NM-CKO-18010 |
Srsf10 |
|
| Sst-(IRES-Cre) |
NM-KI-190091 |
Sst |
Cre tool mouse, somatostatin-expressing neurons |
| Stat4-KO |
NM-KO-190153 |
Stat4 |
Immune-related |
| Stat5a-KO |
NM-KO-190154 |
Stat5a |
Immune-related |
| Stat6-KO |
NM-KO-190155 |
Stat6 |
Immune-related |
| Stc1-KO |
NM-KO-190386 |
Stc1 |
Immune-related |
| Stk11-CKO |
NM-CKO-18014 |
Stk11 |
|
| Stk38l-CKO |
NM-CKO-00060 |
Stk38l |
|
| Stoml1-KO |
NM-KO-190378 |
Stoml1 |
Immune-related |
| Sucnr1-KO |
NM-KO-190387 |
Sucnr1 |
Immune-related |
| Sult1b1-KO |
NM-KO-190388 |
Sult1b1 |
Immune-related |
| Sumf2-CKO |
NM-CKO-00017 |
Sumf2 |
Metabolism of lipids and lipoproteins,Metabolism of proteins,Sphingolipid metabolism |
| Suv39h1-CKO |
NM-CKO-190043 |
Suv39h1 |
Epigenetic |
| Suz12-CKO |
NM-CKO-190044 |
Suz12 |
Epigenetic |
| Syt7-KO |
NM-KO-190389 |
Syt7 |
Immune-related |
| Sytl1-KO |
NM-KO-190377 |
Sytl1 |
Immune-related |
| Tacr2-KO |
NM-KO-00064 |
Tacr2 |
|
| Tango2-KO |
NM-KO-190197 |
Tango2 |
Immune-related |
| TAP-1-KO |
NM-KO-190194 |
TAP-1 |
Immune-related |
| Tat-KO |
NM-KO-190156 |
Tat |
Immune-related |
| Tbcb-CKO |
NM-CKO-00088 |
Tbcb |
homeostasis/metabolism，nervous system， |
| Tbx15-CKO |
NM-CKO-00141 |
Tbx15 |
|
| Tbx21-KO |
NM-KO-190157 |
Tbx21 |
Immune-related |
| Tbxa2r-KO |
NM-KO-190390 |
Tbxa2r |
Immune-related |
| Tcrα-KO |
NM-KO-190434 |
Tcrα |
immune |
| Tcrβ-KO |
NM-KO-190437 |
Tcrβ |
immune |
| Tcrδ-KO |
NM-KO-190435 |
Tcrδ |
immune |
| Tdrp-KO |
NM-KO-00065 |
Tdrp |
genital system |
| Tec-KO |
NM-KO-190158 |
Tec |
Immune-related |
| Tef-KO |
NM-KO-190159 |
Tef |
Immune-related |
| Tert-(CreERT2) |
NM-KI-18037 |
Tert |
Cre recombinase tool |
| R26-(CAG-LSL-V5-TERT-IRES-Luciferase-2A-EGFP-WPRE-pA) |
NM-KI-18035 |
TERT |
Telomerase |
| Tespa1-KO |
NM-KO-00036 |
Tespa1 |
hematopoietic system,immune system |
| Tet1-CKO |
NM-CKO-00075 |
Tet1 |
|
| Tet2-CKO |
NM-CKO-190055 |
Tet2 |
Epigenetic |
| Tet2-KO |
NM-KO-00127 |
Tet2 |
hematopoietic research, cancer research |
| Tet3-CKO |
NM-CKO-18002 |
Tet3 |
Epigenetic,DNA demethylation study |
| Tet3-CKO |
NM-CKO-18003 |
Tet3 |
Epigenetic,DNA demethylation study |
| Tet3-KO |
NM-KO-18007 |
Tet3 |
Epigenetic,DNA demethylation study |
| Tex101-CKO |
NM-CKO-00090 |
Tex101 |
nervous system，Insulin secretion |
| Tfg-KO |
NM-KO-190160 |
Tfg |
Immune-related |
| Tfpi-CKO |
NM-CKO-00044 |
Tfpi |
|
| Tfpi2-CKO |
NM-CKO-00117 |
Tfpi2 |
|
| Tgfb1-CKO |
NM-CKO-00107 |
Tgfb1 |
homeostasis/metabolism，immune system，hematopoietic system |
| Themis-KO |
NM-KO-190161 |
Themis |
Immune-related |
| Thy1-KO |
NM-KO-190162 |
Thy1 |
Immune-related |
| Ticam2-KO |
NM-KO-190391 |
Ticam2 |
Immune-related |
| Tie1-(2A-Cre) |
NM-KI-18023 |
Tie1 |
|
| TIGIT-HU |
NM-HU-190032 |
Tigit |
Immunotherapy,cancer research,drug screening |
| Tigit-KO |
NM-KO-18043 |
Tigit |
immune system |
| TIGIT-HU |
NM-HU-00053 |
Tigit |
Immunotherapy,cancer research,drug screening |
| Tlr1-KO |
NM-KO-190163 |
Tlr1 |
Immune-related |
| Tlr2-KO |
NM-KO-18026 |
Tlr2 |
Immune-related |
| Tlr3-KO |
NM-KO-190431 |
Tlr3 |
Immune-related |
| Tlr3-KO |
NM-KO-190164 |
Tlr3 |
Immune-related |
| Tlr4-KO |
NM-KO-18052 |
Tlr4 |
Immune-related |
| Tlr5-KO |
NM-KO-190430 |
Tlr5 |
Immune-related |
| Tlr5-KO |
NM-KO-18059 |
Tlr5 |
Immune-related |
| TLR6-KO |
NM-KO-190195 |
TLR6 |
Immune-related |
| Tlr7-KO |
NM-KO-190166 |
Tlr7 |
Immune-related |
| TLR7-HU |
NM-HU-18027 |
Tlr7 |
Immunotherapy,Cancer research,Drug screening |
| TLR8-HU |
NM-HU-190044 |
Tlr8 |
Immunotherapy,cancer research,drug screening |
| Tlr8-KO |
NM-KO-190167 |
Tlr8 |
Immune-related |
| TLR9&OX40-HU |
NM-HU-190024 |
Tlr9，Tnfrsf4 |
Immune-related |
| Tlr9-KO |
NM-KO-190168 |
Tlr9 |
Immune-related |
| Tlr9-HU |
NM-HU-18016 |
Tlr9 |
drug screening |
| Tmcc2-KO |
NM-KO-190392 |
Tmcc2 |
Immune-related |
| Tmco3-KO |
NM-KO-190398 |
Tmco3 |
Immune-related |
| Tmed4-CKO |
NM-CKO-00018 |
Tmed4 |
|
| TMEM173-HU |
NM-HU-190036 |
Tmem173 |
Immunotherapy,cancer research,drug screening |
| Tmem173-CKO |
NM-CKO-00014 |
Tmem173 |
Apoptotic process，interferon-beta production，immune response |
| Tmem184a-CKO |
NM-CKO-00142 |
Tmem184a |
|
| Tmem216-KO |
NM-KO-190393 |
Tmem216 |
Immune-related |
| Tmem63a-KO |
NM-KO-190394 |
Tmem63a |
Immune-related |
| Tmem63b-KO |
NM-KO-190395 |
Tmem63b |
Immune-related |
| Tmem63c-KO |
NM-KO-190396 |
Tmem63c |
Immune-related |
| Tmem94-KO |
NM-KO-190397 |
Tmem94 |
Immune-related |
| Tnf-KO |
NM-KO-00100 |
Tnf |
Immune and cancer research |
| Tnfaip2-KO |
NM-KO-190399 |
Tnfaip2 |
Immune-related |
| Tnfrsf11b-KO |
NM-KO-190400 |
Tnfrsf11b |
Immune-related |
| Opg-KO |
NM-KO-00004 |
Tnfrsf11b |
osteoporosis |
| Tnfrsf14-KO |
NM-KO-190439 |
Tnfrsf14 |
Immune-related |
| GITR-HU |
NM-HU-190051 |
Tnfrsf18 |
Immunotherapy,cancer research,drug screening |
| Tnfrsf18-KO |
NM-KO-190424 |
Tnfrsf18 |
Immune-related |
| GITR-HU |
NM-HU-00096 |
Tnfrsf18 |
Immunotherapy,cancer research,drug screening |
| Tnfrsf1a/Tnfrsf1b-KO |
NM-KO-18036 |
Tnfrsf1a，Tnfrsf1b |
|
| TNFRSF1B-HU |
NM-HU-190010 |
Tnfrsf1b |
Immune-related |
| Tnfrsf25-KO |
NM-KO-190169 |
Tnfrsf25 |
Immune-related |
| TNFRSF25-HU |
NM-HU-00097 |
Tnfrsf25 |
Immunotherapy,cancer research,drug screening |
| Tnfrsf4-KO |
NM-KO-190171 |
Tnfrsf4 |
Immune-related |
| OX40-HU |
NM-HU-00078 |
Tnfrsf4 |
cancer research,Immunotherapy,drug screening |
| OX40-HU |
NM-HU-00041 |
Tnfrsf4 |
Immunotherapy,cancer research,drug screening |
| PD-1&PD-L1&OX40-HU |
NM-HU-00122 |
Tnfrsf4，Pdcd1，Cd274 |
Immunotherapy,cancer research,drug screening |
| OX40&CTLA4-HU |
NM-HU-00105 |
Tnfrsf4，Ctla4 |
Immunotherapy,cancer research,drug screening |
| Tnfrsf9-KO |
NM-KO-190173 |
Tnfrsf9 |
Immune-related |
| 4-1BB-KO |
NM-KO-00088 |
Tnfrsf9 |
Immune and hematopoietic research |
| 4-1BB-HU |
NM-HU-00099 |
Tnfrsf9 |
Immunotherapy,cancer research,drug screening |
| Tnfsf10-KO |
NM-KO-190401 |
Tnfsf10 |
Immune-related |
| Tnfsf14-KO |
NM-KO-190170 |
Tnfsf14 |
Immune-related |
| OX40L-HU |
NM-HU-00070 |
Tnfsf4 |
Immunotherapy,cancer research,drug screening |
| 4-1BBL-HU |
NM-HU-00048 |
Tnfsf9 |
Immunotherapy,cancer research,drug screening |
| Tppp3-CKO |
NM-CKO-00085 |
Tppp3 |
|
| Tra2b-CKO |
NM-CKO-00066 |
Tra2b |
Cornelia de Lange syndrome. |
| Traf1-KO |
NM-KO-190442 |
Traf1 |
Immune-related,allergic airway diseases and Rheumatoid arthritis |
| Trdmt1-CKO |
NM-CKO-190045 |
Trdmt1 |
Epigenetic |
| Trem2-CKO |
NM-CKO-190063 |
Trem2 |
Neurobiology Research, Alzheimer's disease related |
| Trem2-(R47H) |
NM-KI-190092 |
Trem2 |
Neurobiology Research,Alzheimer's disease related |
| Trem2-KO |
NM-KO-190402 |
Trem2 |
Immune-related |
| Trib1-KO |
NM-KO-190172 |
Trib1 |
Immune-related |
| Trim21-KO |
NM-KO-190403 |
Trim21 |
Immune-related |
| Trim24-KO |
NM-KO-190404 |
Trim24 |
Immune-related |
| Trim59-KO |
NM-KO-190405 |
Trim59 |
Immune-related |
| Trim67-KO |
NM-KO-190406 |
Trim67 |
Immune-related |
| Trmt6-KO |
NM-KO-190407 |
Trmt6 |
Immune-related |
| Trp53-(R172H) |
NM-KI-18028 |
Trp53 |
cancer research |
| Trp53-(R270H) |
NM-KI-18027 |
Trp53 |
cancer research |
| P53-CKO |
NM-CKO-18005 |
Trp53 |
cancer research |
| P53-KO |
NM-KO-00011 |
Trp53 |
Tumorigenesis，aging，antineoplastic drug evaluation etc |
| Trp63-(DreERT2) |
NM-KI-190029 |
Trp63 |
Dre recombinase tool |
| Trpa1-KO |
NM-KO-190446 |
Trpa1 |
neurobiological studies |
| Trpc6-CKO |
NM-CKO-00104 |
Trpc6 |
homeostasis/metabolism |
| Trpv1-KO |
NM-KO-18053 |
Trpv1 |
|
| Trpv2-CKO |
NM-CKO-00023 |
Trpv2 |
|
| Trpv4-KO |
NM-KO-190408 |
Trpv4 |
Immune-related |
| Trpv6-KO |
NM-KO-00168 |
Trpv6 |
|
| Tslp-KO |
NM-KO-190174 |
Tslp |
Immune-related |
| Tspyl5-KO |
NM-KO-190409 |
Tspyl5 |
Immune-related |
| Ttk-CKO |
NM-CKO-00144 |
Ttk |
|
| Ttr-(G103R) |
NM-KI-00134 |
Ttr |
|
| Tg-(CAG-tTRKRAB) |
NM-TG-00008 |
tTRKRAB |
|
| Txlna-KO |
NM-KO-00123 |
Txlna |
immune system |
| Txlna-(Luc-EGFP) |
NM-KI-00026 |
Txlna |
Inflammation and immunity, gene tracing |
| Tyr-(CreERT2) |
NM-KI-18058 |
Tyr |
Melanocyte Cre tool mouse |
| Tyr-KO |
NM-KO-00132 |
Tyr |
|
| R26-(U6-gRNA-Apoe-Ldlr) |
NM-KI-18005 |
U6-gRNA-Apoe-Ldlr |
|
| Ube2s-CKO |
NM-CKO-00102 |
Ube2s |
hematopoietic system，homeostasis/metabolism，immune system |
| Ucp2-KO |
NM-KO-00038 |
Ucp2 |
nervous system,immune system |
| Uhrf1-CKO |
NM-CKO-00094 |
Uhrf1 |
metabolism，respiratory system |
| Upk3b-KO |
NM-KO-00023 |
Upk3b |
|
| Usp26-KO |
NM-KO-190410 |
Usp26 |
Immune-related |
| Usp4-KO |
NM-KO-190411 |
Usp4 |
Immune-related |
| Virma-CKO |
NM-CKO-190008 |
Virma |
Epigenetic |
| R26-(CAG-LSL-Virma-3xFLAG-IRES-EGFP) |
NM-KI-190057 |
Virma |
mRNA methylation |
| Vps53-CKO |
NM-CKO-00036 |
Vps53 |
|
| Vrtn-KO |
NM-KO-190413 |
Vrtn |
Immune-related |
| Vsir-KO |
NM-KO-18047 |
Vsir |
|
| VISTA-HU |
NM-HU-00118 |
Vsir |
Immunotherapy,cancer research,drug screening |
| Vstm2a-CKO |
NM-CKO-00010 |
Vstm2a |
|
| VTCN1-HU |
NM-HU-190004 |
Vtcn1 |
Immune-related |
| Vwc2l-CKO |
NM-CKO-00005 |
Vwc2l |
|
| Wdr47-CKO |
NM-CKO-00089 |
Wdr47 |
|
| Wls-CKO |
NM-CKO-00027 |
Wls |
Signal Transduction，Signaling by Wnt |
| Wnt7a-KO |
NM-KO-190414 |
Wnt7a |
Immune-related |
| R26-(CAG-LSL-Wtap-3xFLAG-IRES-EGFP) |
NM-KI-190058 |
Wtap |
mRNA methylation |
| Wtap-CKO |
NM-CKO-190009 |
Wtap |
Epigenetic |
| Wwp2-CKO |
NM-CKO-00078 |
Wwp2 |
Cerebral Cavernous Malformations 3（CCM3），cardiovascular system，embryogenesis，immune system，nervous system，mortality/aging |
| Xaf1-KO |
NM-KO-190415 |
Xaf1 |
Immune-related |
| Xcl1-KO |
NM-KO-190175 |
Xcl1 |
Immune-related |
| Xiap-KO |
NM-KO-190176 |
Xiap |
Immune-related |
| Yap1-(linker-GFP) |
NM-KI-18003 |
Yap1 |
|
| Ythdc1-CKO |
NM-CKO-190013 |
Ythdc1 |
Epigenetic |
| R26-(CAG-LSL-Ythdc1-3xFLAG-IRES-EGFP) |
NM-KI-190059 |
Ythdc1 |
mRNA methylation |
| Ythdc2-CKO |
NM-CKO-190014 |
Ythdc2 |
Epigenetic |
| R26-(CAG-LSL-Ythdc2-3xFLAG-IRES-EGFP) |
NM-KI-190060 |
Ythdc2 |
mRNA methylation |
| Ythdf1-CKO |
NM-CKO-190010 |
Ythdf1 |
Epigenetic |
| R26-(CAG-LSL-3xFLAG-Ythdf1-IRES-EGFP) |
NM-KI-190061 |
Ythdf1 |
mRNA methylation |
| Ythdf2-CKO |
NM-CKO-190011 |
Ythdf2 |
Epigenetic |
| R26-(CAG-LSL-3xFLAG-Ythdf3-IRES-EGFP) |
NM-KI-190062 |
Ythdf3 |
mRNA methylation |
| Ythdf3-CKO |
NM-CKO-190012 |
Ythdf3 |
Epigenetic |
| Zan-KO |
NM-KO-190177 |
Zan |
Immune-related |
| Zap70-KO |
NM-KO-190178 |
Zap70 |
Immune-related |
| Zbtb46-(2A-CreERT2-WPRE-pA) |
NM-KI-18021 |
Zbtb46 |
Cre recombinase tool |
| Zc3h12c-KO |
NM-KO-190416 |
Zc3h12c |
Immune-related |
| Zdhhc18-KO |
NM-KO-190417 |
Zdhhc18 |
Immune-related |
| Zdhhc20-KO |
NM-KO-18050 |
Zdhhc20 |
|
| Zfp24-KO |
NM-KO-00010 |
Zfp24 |
aging，nervous system |
| Zfp42-CKO |
NM-CKO-00057 |
Zfp42 |
|
| Zfp91-CKO |
NM-CKO-00046 |
Zfp91 |
|
| Zhx2-KO |
NM-KO-190418 |
Zhx2 |
Immune-related |
| Zic2-KO |
NM-KO-00082 |
Zic2 |
Neural tube, forebrain development |
| Zmpste24-KO |
NM-KO-18011 |
Zmpste24 |
premature aging disease Hutchinson-Gilford progeria syndrome (HGPS) |
| Znrf1-KO |
NM-KO-190419 |
Znrf1 |
Immune-related |
| Zzef1-KO |
NM-KO-190420 |
Zzef1 |
Immune-related |
| H11-(CAG-LSL-mTagBFP2) |
NM-KI-190006 |
|
Fluorescent reporter Mice |
| H11-(pThy1-PSEN1-IRES-tdTomato) |
NM-KI-18049 |
|
Alzheimer's research |
| H11-(CAG-RSR-EYFP) |
NM-KI-18056 |
|
Cell tracing |
| R26-(CAG-LSL-EYFP) |
NM-KI-18055 |
|
Cell tracing |
| R26-(CAG-RSR-mTagBFP2) |
NM-KI-18054 |
|
Cell tracing |
| R26-(EZH2) |
NM-KI-18053 |
|
Tumor research; drug screening |
| R26-(C-MET) |
NM-KI-18052 |
|
Tumor research; drug screening |
| R26-(CAG-LSL-luci-tdTomato-V5) |
NM-KI-18051 |
|
Cell tracing |
| R26-(NRF2) |
NM-KI-18050 |
|
Tumor research; drug screening |
| R26-(SA-V5-M2rtTA-FRT-WPRE-FRT-polyA-attb-PGK-Neo-polyA-attp) |
NM-KI-18025 |
|
gene regulation tool |
| R26-(CAG-LSL-PyMT-IRES-Luc-2A-tdtomato) |
NM-KI-18022 |
|
|
| H11-(CAG-RSR-tdTomato) |
NM-KI-18009 |
|
gene tracing |
| HBV-TG |
NM-TG-00003 |
|
HBV |
| MMTV-PLAG1 |
NM-TG-00004 |
|
salivary gland tumor research |
